US20210000060A1 - Materials and methods for modulating seed size, seed number, and seed sugar content in plants - Google Patents
Materials and methods for modulating seed size, seed number, and seed sugar content in plants Download PDFInfo
- Publication number
- US20210000060A1 US20210000060A1 US17/019,951 US202017019951A US2021000060A1 US 20210000060 A1 US20210000060 A1 US 20210000060A1 US 202017019951 A US202017019951 A US 202017019951A US 2021000060 A1 US2021000060 A1 US 2021000060A1
- Authority
- US
- United States
- Prior art keywords
- plant
- sdh
- gene
- maize
- mutant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 55
- 235000000346 sugar Nutrition 0.000 title claims abstract description 38
- 239000000463 material Substances 0.000 title abstract description 11
- 108010009384 L-Iditol 2-Dehydrogenase Proteins 0.000 claims abstract description 120
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 113
- 230000014509 gene expression Effects 0.000 claims abstract description 93
- 102100026974 Sorbitol dehydrogenase Human genes 0.000 claims abstract description 89
- 101150098704 SDH gene Proteins 0.000 claims abstract description 61
- 230000001965 increasing effect Effects 0.000 claims abstract description 51
- 230000003247 decreasing effect Effects 0.000 claims abstract description 46
- 241000196324 Embryophyta Species 0.000 claims description 173
- 108091033319 polynucleotide Proteins 0.000 claims description 128
- 102000040430 polynucleotide Human genes 0.000 claims description 128
- 239000002157 polynucleotide Substances 0.000 claims description 128
- 240000008042 Zea mays Species 0.000 claims description 72
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 60
- 125000003729 nucleotide group Chemical group 0.000 claims description 49
- 239000002773 nucleotide Substances 0.000 claims description 48
- 102000004190 Enzymes Human genes 0.000 claims description 26
- 108090000790 Enzymes Proteins 0.000 claims description 26
- 239000005715 Fructose Substances 0.000 claims description 23
- 229930091371 Fructose Natural products 0.000 claims description 22
- 230000002255 enzymatic effect Effects 0.000 claims description 22
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 21
- 229930006000 Sucrose Natural products 0.000 claims description 15
- 239000005720 sucrose Substances 0.000 claims description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 108700009124 Transcription Initiation Site Proteins 0.000 claims description 12
- 241000482268 Zea mays subsp. mays Species 0.000 claims description 12
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 12
- 239000008103 glucose Substances 0.000 claims description 12
- 230000010152 pollination Effects 0.000 claims description 12
- 229920002472 Starch Polymers 0.000 claims description 7
- 238000003780 insertion Methods 0.000 claims description 7
- 230000037431 insertion Effects 0.000 claims description 7
- 235000019698 starch Nutrition 0.000 claims description 7
- 239000008107 starch Substances 0.000 claims description 7
- 230000009261 transgenic effect Effects 0.000 claims description 7
- 238000011144 upstream manufacturing Methods 0.000 claims description 6
- 238000003306 harvesting Methods 0.000 claims description 4
- 108700001094 Plant Genes Proteins 0.000 claims description 3
- 235000007244 Zea mays Nutrition 0.000 claims description 3
- 108091023040 Transcription factor Proteins 0.000 claims description 2
- 102000040945 Transcription factor Human genes 0.000 claims description 2
- 125000000185 sucrose group Chemical group 0.000 claims 3
- 230000005764 inhibitory process Effects 0.000 claims 2
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 abstract description 10
- 239000000600 sorbitol Substances 0.000 description 59
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 58
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 58
- 210000004027 cell Anatomy 0.000 description 50
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 47
- 235000009973 maize Nutrition 0.000 description 47
- 230000000694 effects Effects 0.000 description 37
- 235000001014 amino acid Nutrition 0.000 description 36
- 229940024606 amino acid Drugs 0.000 description 35
- 150000001413 amino acids Chemical class 0.000 description 34
- 239000012634 fragment Substances 0.000 description 34
- 210000001519 tissue Anatomy 0.000 description 33
- 239000000047 product Substances 0.000 description 26
- 230000035772 mutation Effects 0.000 description 25
- 229920001184 polypeptide Polymers 0.000 description 25
- 108090000765 processed proteins & peptides Proteins 0.000 description 25
- 102000004196 processed proteins & peptides Human genes 0.000 description 25
- 101150021944 SORD gene Proteins 0.000 description 24
- 235000018102 proteins Nutrition 0.000 description 24
- 102000004169 proteins and genes Human genes 0.000 description 24
- 229940088598 enzyme Drugs 0.000 description 23
- 150000007523 nucleic acids Chemical group 0.000 description 22
- 108020004999 messenger RNA Proteins 0.000 description 21
- 230000000692 anti-sense effect Effects 0.000 description 17
- 125000003275 alpha amino acid group Chemical group 0.000 description 16
- 239000000523 sample Substances 0.000 description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 description 14
- 244000070406 Malus silvestris Species 0.000 description 13
- 235000011430 Malus pumila Nutrition 0.000 description 12
- 235000015103 Malus silvestris Nutrition 0.000 description 12
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 12
- 230000000295 complement effect Effects 0.000 description 12
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 11
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 230000009368 gene silencing by RNA Effects 0.000 description 11
- 239000013615 primer Substances 0.000 description 11
- 230000001105 regulatory effect Effects 0.000 description 11
- 230000014616 translation Effects 0.000 description 11
- 101710117590 Sorbitol dehydrogenase 1 Proteins 0.000 description 10
- 239000002987 primer (paints) Substances 0.000 description 10
- 238000013519 translation Methods 0.000 description 10
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 9
- 210000002257 embryonic structure Anatomy 0.000 description 9
- 238000006467 substitution reaction Methods 0.000 description 9
- 102000016912 Aldehyde Reductase Human genes 0.000 description 8
- 108010053754 Aldehyde reductase Proteins 0.000 description 8
- 108090000994 Catalytic RNA Proteins 0.000 description 8
- 102000053642 Catalytic RNA Human genes 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 8
- 108020004459 Small interfering RNA Proteins 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 8
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 8
- 238000003752 polymerase chain reaction Methods 0.000 description 8
- 108091092562 ribozyme Proteins 0.000 description 8
- 239000004055 small Interfering RNA Substances 0.000 description 8
- 108091034117 Oligonucleotide Proteins 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 235000013399 edible fruits Nutrition 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 238000010561 standard procedure Methods 0.000 description 7
- 125000003821 2-(trimethylsilyl)ethoxymethyl group Chemical group [H]C([H])([H])[Si](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(OC([H])([H])[*])([H])[H] 0.000 description 6
- 241000701489 Cauliflower mosaic virus Species 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 210000005069 ears Anatomy 0.000 description 6
- 238000004626 scanning electron microscopy Methods 0.000 description 6
- 108700028369 Alleles Proteins 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 150000005846 sugar alcohols Chemical class 0.000 description 5
- 150000008163 sugars Chemical class 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- GACTWZZMVMUKNG-UHFFFAOYSA-N D-sorbitol phosphate Natural products OCC(O)C(O)C(O)C(O)COP(O)(O)=O GACTWZZMVMUKNG-UHFFFAOYSA-N 0.000 description 4
- 239000000074 antisense oligonucleotide Substances 0.000 description 4
- 238000012230 antisense oligonucleotides Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 230000008774 maternal effect Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000011535 reaction buffer Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 230000011664 signaling Effects 0.000 description 4
- GACTWZZMVMUKNG-ZXXMMSQZSA-N sorbitol 6-phosphate Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)COP(O)(O)=O GACTWZZMVMUKNG-ZXXMMSQZSA-N 0.000 description 4
- 230000005030 transcription termination Effects 0.000 description 4
- FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 3
- 244000144730 Amygdalus persica Species 0.000 description 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Chemical compound OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 3
- 108091026890 Coding region Proteins 0.000 description 3
- 108091033380 Coding strand Proteins 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 235000006040 Prunus persica var persica Nutrition 0.000 description 3
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 3
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 3
- 101001036768 Zea mays Glucose-1-phosphate adenylyltransferase large subunit 1, chloroplastic/amyloplastic Proteins 0.000 description 3
- 229920002494 Zein Polymers 0.000 description 3
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000000408 embryogenic effect Effects 0.000 description 3
- -1 fluoro-amino Chemical class 0.000 description 3
- 230000005714 functional activity Effects 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000018791 negative regulation of catalytic activity Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000003827 upregulation Effects 0.000 description 3
- 229940093612 zein Drugs 0.000 description 3
- 239000005019 zein Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- RFLVMTUMFYRZCB-UHFFFAOYSA-N 1-methylguanine Chemical compound O=C1N(C)C(N)=NC2=C1N=CN2 RFLVMTUMFYRZCB-UHFFFAOYSA-N 0.000 description 2
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 101710190411 Chalcone synthase A Proteins 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 240000003183 Manihot esculenta Species 0.000 description 2
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 241001479493 Sousa Species 0.000 description 2
- 108010043934 Sucrose synthase Proteins 0.000 description 2
- 108090000848 Ubiquitin Proteins 0.000 description 2
- 102000044159 Ubiquitin Human genes 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- XVOYSCVBGLVSOL-UHFFFAOYSA-N cysteic acid Chemical compound OC(=O)C(N)CS(O)(=O)=O XVOYSCVBGLVSOL-UHFFFAOYSA-N 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 230000029553 photosynthesis Effects 0.000 description 2
- 238000010672 photosynthesis Methods 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 108010069925 sorbitol-6-phosphate dehydrogenase Proteins 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansÀure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- BVAUMRCGVHUWOZ-ZETCQYMHSA-N (2s)-2-(cyclohexylazaniumyl)propanoate Chemical class OC(=O)[C@H](C)NC1CCCCC1 BVAUMRCGVHUWOZ-ZETCQYMHSA-N 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- 101100520142 Caenorhabditis elegans pin-2 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 235000010523 Cicer arietinum Nutrition 0.000 description 1
- 244000045195 Cicer arietinum Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 101000737786 Daucus carota Calcium-dependent protein kinase Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241001125671 Eretmochelys imbricata Species 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 101000737787 Glycine max Calcium-dependent protein kinase SK5 Proteins 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 101100408961 Homo sapiens PPP4R1 gene Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 125000000998 L-alanino group Chemical group [H]N([*])[C@](C([H])([H])[H])([H])C(=O)O[H] 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- XIGSAGMEBXLVJJ-YFKPBYRVSA-N L-homocitrulline Chemical compound NC(=O)NCCCC[C@H]([NH3+])C([O-])=O XIGSAGMEBXLVJJ-YFKPBYRVSA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 description 1
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 description 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 101100420573 Malus domestica S6PDH gene Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100496164 Mus musculus Clgn gene Proteins 0.000 description 1
- 101100229966 Mus musculus Grb10 gene Proteins 0.000 description 1
- 101100237027 Mus musculus Meig1 gene Proteins 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 244000062780 Petroselinum sativum Species 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 241001290151 Prunus avium subsp. avium Species 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 101100333547 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ENP1 gene Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102100028618 Serine/threonine-protein phosphatase 4 regulatory subunit 1 Human genes 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241000223892 Tetrahymena Species 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 108010020764 Transposases Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 101100022811 Zea mays MEG1 gene Proteins 0.000 description 1
- 101000662549 Zea mays Sucrose synthase 1 Proteins 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 101150069317 alcA gene Proteins 0.000 description 1
- 150000001323 aldoses Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000021015 bananas Nutrition 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Chemical group C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000007622 bioinformatic analysis Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004900 c-terminal fragment Anatomy 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000008469 cellular response to desiccation Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 230000009850 completed effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003413 degradative effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000021759 endosperm development Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000008124 floral development Effects 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 1
- 108010083391 glycinin Proteins 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 230000010039 intracellular degradation Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000000250 methylamino group Chemical class [H]N(*)C([H])([H])[H] 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- ZLVYMPOQNJTFSG-QMMMGPOBSA-N monoiodotyrosine Chemical compound OC(=O)[C@@H](NI)CC1=CC=C(O)C=C1 ZLVYMPOQNJTFSG-QMMMGPOBSA-N 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000001426 native polyacrylamide gel electrophoresis Methods 0.000 description 1
- 108010058731 nopaline synthase Proteins 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000001033 osmoprotective effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008775 paternal effect Effects 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000007226 seed germination Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- 108010038899 sorbitol oxidase Proteins 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000006491 synthase reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 125000004149 thio group Chemical group *S* 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 101150019416 trpA gene Proteins 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
- A01H6/46—Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
- A01H6/4684—Zea mays [maize]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H5/00—Angiosperms, i.e. flowering plants, characterised by their plant parts; Angiosperms characterised otherwise than by their botanic taxonomy
- A01H5/10—Seeds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8245—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8262—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
Definitions
- Sorbitol is a primary end-product for photosynthesis and a major carbohydrate translocated by many economically-important fruit trees. These are mainly members of two Rosaceaeous subfamilies (Pomoideae and Prunoideae), and include apple, pear, peach, cherry, apricot, and plum (Bieleski and Redgwell, 1985; Loescher and Everard, 1996; Oura et al., 2000). Both sorbitol and sucrose are transported from source leaves to sink tissues such as fruit and shoot tips (Bieleski, 1982; Loescher, 1987). In these species, sorbitol accounts for 50-90% of the C fixed and exported from source leaves (Webb and Burley, 1962; Bieleski and Redgwell, 1985).
- Sorbitol synthesis shares a common hexose-phosphate pool with sucrose synthesis in the cytosol.
- G6P is first converted to sorbitol 6-phosphate by aldose 6-phosphate reductase (A6PR; EC 1.1.1.200, also called sorbitol-6-phosphate dehydrogenase, S6PDH), followed by hydrolysis of sorbitol 6-phosphate to form sorbitol via sorbitol-6-phosphate phosphatase (SorPP; EC 3.1.3.50).
- A6PR aldose 6-phosphate reductase
- S6PDH sorbitol-6-phosphate dehydrogenase
- SorPP sorbitol-6-phosphate phosphatase
- A6PR catalyzes the key regulatory step in sorbitol synthesis (Negm and Loescher 1981; Zhou et al., 2003; Park et al., 2002; Yamada et al., 1998).
- Sorbitol dehydrogenases are active in plants, animals, and microorganisms (Touster and Shaw 1962; Bieleski, 1982). The enzyme was first purified from rat liver (Blakley, 1951), and has since been purified and characterized from many sources (Maret and Auld, 1988; Ng et al., 1992; Yamagushi et al., 1994; Marini et al., 1997).
- SDH SDH was partially purified and characterized from apple callus (Negm and Loescher, 1979) and maize kernels (Doehlert, 1987), followed by subsequent purification from apple fruits (Yamagushi et al., 1994). SDH activity is high in young apple leaves (Loescher et al., 1982), peach leaves (Merlo and Passera, 1991), and in shoot apecies of peach (Lo Bianco et al., 1999a, Lo Bianco et al., 1999b). In these species, SDH is considered a good indicator of sink strength, which is consistent with its active expression in developing apple fruit (Nosarszewski et al., 2004).
- Sorbitol may also share some functions with other sugar-alcohols. Mannitol, for example has been proposed to function in dissipation of excess reducing power during photosynthesis by celery (Loescher, 1987). This was considered a possible contributor to the unusual photosynthetic features of this plant. Other roles for sugar alcohols have included their function as protectants against osmotic, ionic, and temperature stress (Everard et al., 1994; Noiraud et al., 2000).
- sorbitol In maize, the roles of sorbitol remain unclear. It does not appear to have a long-distance transport function, since sorbitol levels are below detection in maize phloem (Zimmerman and Ziegler, 1975). In addition, although sorbitol can be abundant in developing kernels (Carey, 1982; Doehlert and Kuo, 1990), levels drop as the grains mature. Any osmo-protective roles of sorbitol in kernels would thus be limited to periods prior to onset of desiccation tolerance. Nonetheless, significant amounts of photosynthate are partitioned to sorbitol as assimilates enter kernels (Shaw and Dickinson, 1984).
- fructose may follow a less well-known fate in kernels, where it can be converted to sorbitol by sorbitol dehydrogenase (SDH, EC 1.1.1.14).
- SDH sorbitol dehydrogenase
- Km [fructose] 136 mM and Km [sorbitol] 8.45 mM; Doehlert, 1987) would favor sorbitol biosynthesis in high-fructose tissues.
- Plant glycolysis is especially versatile in this regard (Plaxton and Podesta, 2006; Koch 2004; Huber and Akazawa, 1986), but supplies of NAD could become limiting under low-O2 conditions. Elevated NADH levels in the maize endosperm would favor a sorbitol-producing role for SDH and its potential dissipation (or balance) of excess reducing power. Any short-distance movement of sorbitol to better-oxygenated areas, such as embryos, could facilitate generation of NADH and fructose for use at those sites. Other endosperm regions may also be locales of sorbitol use, since metabolic gradients in this structure can be marked (Rolletschek et al., 2005).
- the maize and rice genomes lack any genes or proteins with sequence similarity to the apple sorbitol-6-phosphate phosphatase or aldose-6-phosphate reductase. Sequence similarities were also lacking for any maize or rice genes that might encode apple-like enzymes of NADP-dependent sorbitol dehydrogenase (converts sorbitol to glucose), an NADP-dependent sorbitol 6-P dehydrogenase (converts sorbitol 6-P to glucose 6-P), or a sorbitol oxidase (converts sorbitol to glucose independent of either NAD or NADP).
- NADP-dependent sorbitol dehydrogenase converts sorbitol to glucose
- an NADP-dependent sorbitol 6-P dehydrogenase converts sorbitol 6-P to glucose 6-P
- a sorbitol oxidase converts sorbitol to glucose independent of either NAD or NADP
- seed size is decreased relative to wild type seed by inhibiting or knocking out expression of a sorbitol dehydrogenase (Sdh) gene or the gene product thereof.
- seed size is increased relative to wild type seed by increasing expression of an Sdh gene or the gene product thereof.
- an Sdh gene is overexpressed.
- seed number is increased relative to wild type seed by inhibiting or knocking out expression of a sorbitol dehydrogenase (Sdh) gene or the gene product thereof.
- seed number is decreased relative to wild type seed by increasing expression of an Sdh gene or the gene product thereof.
- an Sdh gene is overexpressed.
- seed sugar content is increased relative to wild type seed by inhibiting or knocking out expression of a sorbitol dehydrogenase (Sdh) gene or the gene product thereof.
- seed sugar content is decreased relative to wild type seed by increasing expression of an Sdh gene or the gene product thereof.
- an Sdh gene is overexpressed.
- FIG. 1 shows oxygen levels drop to limits of detection or below in endosperm, but not embryos of maize kernels at 300mg FW. Oxygen microprope path is shown along the x axis. ( Figure adapted from Rolletshek et al. 2005). Implications for kernel metabolism are profound.
- FIG. 2 shows sites of Sorbitol dehydrogenase-1 expression at the level of Sdh1 mRNA (upper panel) and SDH activity (lower panel), with Etbr loading controls in the mid panel.
- a 400-bp Sdh1 probe was used for RNA gel blot analyses.
- Activity assays in native PAGE were conducted with reaction buffer containing 68 mM sorbitol, 0.15 mM NAD, 0.18 mM nitro blue tetrazolium, 0.06 mM phenazine methasulfate, and 50 mM Tris-HCl, pH 8.0.
- FIG. 3 shows SDH activity that was histochemically localized in longitudinally bisected fresh kernels (2 shown) at 20 DAP. One half of each kernel was exposed to reaction buffer with sorbitol for A & B, whereas sorbitol was omitted for control halves C & D. Blue color denotes activity.
- FIGS. 4A-4B show possible scenarios for metabolic roles of sorbitol in maize kernels.
- FIG. 4A shows a mostly-hypothetical model for whole kernels, but the first portion (role of SDH) can now be tested. Also, preliminary evidence is consistent with sorbitol transfer from endosperm to embryo (see FIG. 5 and text).
- FIG. 4B shows how the reversible SDH reaction could also contribute to metabolic cycling with the potential to aid balance of key reactants and/or shuttle them from one site to another. This possibility would include control of pool sizes for potential signaling molecules (like fructose) or redox control (as for NAD/NADH), and could operate in tissues other than seeds (e.g., floral apecies).
- FIGS. 5A-5F show maize embryos (14 DAP) grown in MS (4.3 g/l) salts for 7 days with or without the following supplements.
- FIG. 5A MS alone
- FIG. 5B sorbitol (87.65 mM)
- FIG. 5C mannitol (87.65 mM)
- FIG. 5D sucrose (87.65 mM)
- FIG. 5E glucose (87.65 mM)
- FIG. 5F fructose (87.65 mM).
- FIGS. 6A-6B show sucrose effects on levels of Sdh1 mRNA and SDH enzyme activity in maize kernels 8 hours after ear injections of sucrose at levels shown.
- FIG. 6A shows an RNA gel blot with a 400 pb SDH probe. An EtBr control is shown in the lower panel.
- FIG. 6B shows activity of SDH in sample fractions from the same maize kernels assayed at 30° C., pH 9.0, and 2 mM NAD.
- FIG. 7 shows elevated expression of Sorbitol dehydrogenase-1 (Sdh1) in the shrunken2 âsweet cornâ mutant.
- FIG. 8 shows a Mu insert in an sdh1 (Sorbitol dehydrogenasel) gene from a mutant isolated using the Uniform-Mu Maize Reverse Genetics Grid 1. Two points of intersection were observed. The sdh1 mutant was isolated from one, and the other is probably a related line. DNA traced to Plant 02S-1032-04.
- sdh1 Sorbitol dehydrogenasel
- FIGS. 9A-9B show in situ activity of SDH in maize kernels (25 DAP)
- FIG. 9A A. wild type and B. sdh1-mutant kernels incubated with reaction buffer (68 mM sorbitol, 0.15 mM NAD, 0.18 mM nitro blue tetrazolium, 0.06 mM phenazine methasulfate and 50 mM Tris-HCl, pH 8.0).
- FIG. 9A A. wild type and B. sdh1-mutant kernels incubated with reaction buffer (68 mM sorbitol, 0.15 mM NAD, 0.18 mM nitro blue tetrazolium, 0.06 mM phenazine methasulfate and 50 mM Tris-HCl, pH 8.0).
- 9B shows activity of sorbitol dehydrogenase enzyme in wild type and sdh1 maize kernels during endosperm development (10, 15, 20 and 25 DAP) assayed at 30° C., pH 9.0, and 2 mM NAD. Error bars are SEMs of 3 replications.
- FIG. 10A shows maize ears and kernels of wildtype (left) and sdh1-mutant plants (right). Kernels were magnified 0.8 â .
- FIG. 10B dried-seed weight is shown for wildtype and sdh1-mutant kernels, all at 12% moisture (g). Additional results (not shown) were similar for subsequent studies of field- and greenhouse-grown plants (sdh1 kernels consistently 18 to 21% smaller).
- FIG. 11 shows total kernels per ear on wild-type (wt) (shaded bar) and sdh mutant plants (unshaded bar) in an inbred W22 background. Plants were grown in 30-L containers under 12-h, light-supplemented greenhouse conditions (November-January) in Gainesville, Fla. Totals for wt and sdh mothers (**) differed at the 0.2% level p â 0.002), with error bars denoting SEMs. Plant genotypes were verified by PCR. Similar results (not shown) were obtained from subsequent analyses of field-grown plants.
- FIG. 12A shows total kernels per ear on wild-type (wt) (shaded bars) and sdh mutant plants (unshaded bars) in an inbred W22 background. Effects of male and female parents are shown as contributions from wild-type (wt) and sdh mutant plants to crosses (denoted at figure base). Similar results (not shown) were obtained from subsequent analyses of field-grown plants.
- FIG. 12B shows weight of dried ears from the same individuals sampled for kernel number in FIG. 12A . Plants were grown in 30-L containers under 12-h, light-supplemented greenhouse conditions (November-January) in Gainesville, Fla.
- FIGS. 13A-13D show mutant and maternal effects on ear features of (wt) (shaded bars), Sdh mutant plants (unshaded bars), in an inbred W22 background. Bars at the left of each panel compare ears from all wt females to those of all sdh mutant females regardless of the pollen parent utilized (wt or sdh).
- FIG. 13A shows kernels per ear; FIG. 13B shows kernels per row; FIG. 13C shows rows per ear, and FIG. 13D shows ear length. Plants were grown in 30-L containers under 12-h, light-supplemented greenhouse conditions (November-January) in Gainesville, Fla.
- FIGS. 14A-14B show mutant sdh1 genes in B73 and W22 inbreds.
- FIG. 14A is a diagram of insert sites for currently-known transposon-induced mutations in sdh1 genes.
- the W22 mutations have Mu-transposons inserted immediately upstream or downstream of the putative transcription start site (-17 bp for a newly-identified sdh1-2 allele, and +90 bp for the sdh1-1 allele (data in Figures were obtained for the sdh1-1 allele)).
- FIG. 14B is a comparison of the 5âČ sequence from the wildtype Sdh1 (Sorbitol dehydrogenase 1) gene of W22 to that of the âwildtypeâ sdh1 of B73.
- the B73 sdh1 sequence is shown on the upper line (SEQ ID NO:4), with a portion of the wildtype W22 Sdh1 sequence immediately below it (SEQ ID NO:5).
- the consensus sequence (SEQ ID NO:6) appears on the third line, and red denotes identical sequences.
- the transposon insert in the B73 sdh1 gene is shown in black between bp positions 588 and 712.
- the W22 sdh1-1 and sdh1-2 insert sites would lie at positions 942 and 834, respectively (triangles).
- the putative transcription start site is at position 852 (arrow), and the translation start site is at 1032 (not shown).
- FIG. 15 shows Sdh1 (Sorbitol dehydrogenase 1) expression at the mRNA level during development of B73 (open squares) and W22 (solid triangles) kernels.
- FIG. 16 shows elevated levels of sucrose, glucose, and fructose in sdh1 mutant kernels when compared to wildtype kernels at stages of development when sweet corn is typically harvested (between 20 and 25 DAP).
- dried-seed weight was measured at 12% moisture (g). Error bars show SEMs of 3 biological replications.
- Soluble sugars were extracted three times from each sample using 80% ethanol (with xylose added as an internal control) at 80° C., and eluted with water. A 50-ul sample was injected into a Waters 2410 HPLC equipped with an refractive index detector. The sugars were separated on a Bio-Rad HPX-87C carbohydrate column.
- FIG. 17 shows kernel starch (g 100g â 1 kernel) and zein content in wildtype and sdh1-mutant kernels.
- the sdh1 mutant kernels have about 25% less starch than wildtype at maturity.
- Both sdh1 and wildtype kernels have similar zein content and total protein (wt: 336.26 â 28.85; sdh1: 404.37 â 39.96).
- Dried seed weight of kernels was measured at 12% moisture (g). Error bars are SEMs of 3 replications.
- SEQ ID NO: 1 is an amino acid sequence of a mutant sorbitol dehydrogenase 1 enzyme that can be used according to the present invention.
- SEQ ID NO: 2 is a nucleotide sequence that includes a coding region that encodes the amino acid sequence of SEQ ID NO: 1.
- SEQ ID NO: 3 is a nucleotide sequence that encodes the amino acid sequence of SEQ ID NO: 1.
- seed size is decreased relative to wild type seed by inhibiting or knocking out expression of a Sorbitol dehydrogenase (Sdh) gene or the gene product thereof, or a gene linked to the Sdh gene or the expression thereof.
- Sorbitol dehydrogenase Sorbitol dehydrogenase
- Any means for inhibiting or knocking out expression of a Sdh gene or gene product, or a gene linked thereto, is contemplated within the scope of the present invention.
- Sdh expression can be inhibited using antisense, short interfering RNA (siRNA), or ribozyme technologies.
- Sdh expression can be inhibited in a plant by incorporating a polynucleotide into the plant that provides for an oligonucleotide that is antisense to at least a portion of a nucleotide sequence of an Sdh polynucleotide.
- Sdh expression can be inhibited in a plant by incorporating a polynucleotide into the plant that provides for a siRNA molecule capable of directing or mediating RNA interference (RNAi) of Sdh expression.
- RNAi RNA interference
- Sdh expression can be inhibited in a plant by incorporating a polynucleotide into the plant that encodes a ribozyme that cleaves or inactivates an Sdh RNA.
- a mutant sdh-encoding polynucleotide is introduced into the genome of a target plant.
- the mutant sdh-encoding polynucleotide encodes a mutant sorbitol dehydrogenase enzyme with decreased enzymatic activity relative to a non-mutated or wild type SDH enzyme.
- the mutant sorbitol dehydrogenase enzyme comprises the amino acid sequence shown in SEQ ID NO:1, or a fragment, or variant thereof.
- the polynucleotide encoding SEQ ID NO:1 comprises the nucleotide sequence shown in SEQ ID NO:2 or SEQ ID NO:3, or a fragment or variant thereof.
- a mutant sdh polynucleotide comprises a mutant nucleotide sequence shown in FIG. 14B , or a fragment or variant thereof.
- a mutant sdh gene is incorporated into the genome of a target plant wherein the mutant sdh gene exhibits decreased or no expression of gene transcripts or translation thereof.
- a mutation is introduced into an Sdh gene of a plant that results in decreased transcription of the Sdh gene, or decreased translation of sorbitol dehydrogenase mRNA, and/or that results in a protein exhibiting decreased sorbitol dehydrogenase enzymatic activity.
- a mutation is introduced in the Sdh gene upstream of the transcription start site and/or downstream of the transcription start site.
- a mutation is introduced into or near a regulatory sequence of an Sdh gene, e.g., in a promoter sequence.
- the mutation may block or inhibit transcription of the Sdh gene sequence, e.g., by blocking or inhibiting binding of transcription factors or polymerase to the Sdh nucleic acid sequence.
- a mutation is introduced in the protein coding region of the Sdh gene. Mutations include one or more nucleotide(s) insertions, deletions, or substitutions. Methods for introducing mutations are known in the art.
- seed size is increased relative to wild type seed by increasing expression of an Sdh gene or the gene product thereof, or a gene linked to the Sdh gene or the expression thereof.
- an Sdh gene is overexpressed. Overexpression of Sdh can be achieved using any number of means known in the art and all such means are contemplated within the scope of the invention. For example, a plant can be transformed with multiple copies of a polynucleotide encoding Sdh.
- a plant in another embodiment, can be transformed with a polynucleotide encoding Sdh, wherein the polynucleotide comprises a promoter and/or other regulatory sequences that provide for increased expression of the polynucleotide, or the Sdh gene product.
- a method of the invention comprises introducing or incorporating a polynucleotide into a plant wherein the polynucleotide or the expression product thereof provides for increased expression of Sdh gene or SDH protein relative to a plant wherein the polynucleotide has not been introduced (e.g., a wild type plant).
- a polynucleotide can be introduced that inhibits or decreases degradation of Sdh gene transcripts or gene product.
- a polynucleotide can be introduced that encodes an SDH protein that exhibits increased enzymatic activity (for example, via increased resistance to inhibition of enzyme activity).
- a polynucleotide can be introduced that encodes a protein having SDH enzyme activity, wherein the polynucleotide comprises regulatory elements, such as a promoter and/or enhancer sequences, that provide for increased expression of the polynucleotide and/or the protein encoded thereby.
- the promoter sequence is one that provides for constitutive or tissue-specific (e.g., endosperm) expression. Plants containing the polynucleotide, or progeny thereof, optionally can be screened for increased expression of Sdh gene and/or SDH protein, and/or increased seed or kernel size.
- the subject invention also concerns a mutant sdh plant gene, wherein a plant expressing the mutant gene exhibits decreased levels of gene expression and/or the gene product thereof exhibits decreased levels of SDH enzymatic activity.
- sugar content can refer to sugars, e.g., fructose, sucrose, and glucose, and to sugar alcohols, e.g., sorbitol.
- seed number and sugar content is increased relative to wild type seed by inhibiting or knocking out expression of a sorbitol dehydrogenase (sdh) gene or the gene product thereof, or a gene linked to the Sdh gene or the expression of the Sdh gene. Any means for inhibiting or knocking out expression of a Sdh gene or gene product, or a gene linked thereto, is contemplated within the scope of the present invention.
- sdh sorbitol dehydrogenase
- Sdh expression can be inhibited using antisense or siRNA technologies.
- a mutant sdh-encoding polynucleotide is introduced into the genome of a target plant.
- the mutant sdh-encoding polynucleotide encodes a mutant sorbitol dehydrogenase enzyme with decreased enzymatic activity relative to a non-mutated or wild type SDH enzyme.
- the mutant sorbitol dehydrogenase enzyme comprises the amino acid sequence shown in SEQ ID NO:1, or a fragment, or variant thereof.
- the polynucleotide encoding SEQ ID NO:1 comprises the nucleotide sequence shown in SEQ ID NO:2 or SEQ ID NO:3, or a fragment or variant thereof.
- a mutant sdh polynucleotide comprises a mutant nucleotide sequence shown in FIG. 14B , or a fragment of variant of the sequence.
- a mutant sdh gene is incorporated into the genome of a target plant wherein the mutant sdh gene exhibits decreased or no expression of gene transcripts or translation thereof.
- a mutation is introduced into an Sdh gene of a plant that results in decreased transcription of the Sdh gene, or decreased translation of sorbitol dehydrogenase mRNA, and/or that results in a protein exhibiting decreased sorbitol dehydrogenase enzymatic activity.
- a mutation is introduced in the Sdh gene upstream of the transcription start site and/or downstream of the transcription start site.
- a mutation is introduced in the protein coding region of the Sdh gene. Mutations include one or more nucleotide(s) insertions, deletions, or substitutions. Methods for introducing mutations are known in the art. Plants containing a mutant sdh polynucleotide, or progeny thereof, optionally can be screened for expression of a mutant sdh gene or gene product, and/or increased seed number and/or sugar content.
- seed number and sugar content is decreased relative to wild type seed by increasing expression of an Sdh gene or the gene product thereof, or a gene linked to the Sdh gene or the expression of the Sdh gene.
- an Sdh gene is overexpressed.
- Overexpression of Sdh can be achieved using any number of means known in the art.
- a plant can be transformed with multiple copies of a polynucleotide encoding Sdh.
- a plant can be transformed with a polynucleotide encoding Sdh, wherein the polynucleotide comprises a promoter and/or other regulatory sequences that provide for increased expression of the polynucleotide, or the Sdh gene product.
- a method of the invention comprises introducing a polynucleotide into a plant wherein the polynucleotide or the expression product thereof provides for increased expression of Sdh gene or SDH protein relative to a plant wherein the polynucleotide has not been introduced (e.g., a wild type plant).
- a polynucleotide can be introduced that inhibits or decreases degradation of Sdh gene transcripts or gene product.
- a polynucleotide can be introduced that encodes an SDH protein that exhibits increased enzymatic activity (for example, via increased resistance to inhibition of enzyme activity).
- a polynucleotide can be introduced that encodes a protein having SDH enzyme activity, wherein the polynucleotide comprises regulatory elements, such as a promoter and/or enhancer sequences, that provide for increased expression of the polynucleotide and/or the protein encoded thereby.
- the promoter sequence is one that provides for constitutive or tissue-specific (e.g., endosperm) expression. Plants containing the polynucleotide, or progeny thereof, optionally can be screened for increased expression of Sdh gene and/or SDH protein, and/or decreased seed or kernel number and/or sugar content.
- a method of the invention comprises introducing a polynucleotide into a plant wherein the polynucleotide or the expression product thereof provides for decreased expression of Sdh gene or SDH protein relative to a plant wherein the polynucleotide has not been introduced (e.g., a wild type plant).
- a polynucleotide can be introduced that increases degradation of Sdh gene transcripts or gene product.
- a polynucleotide can be introduced that encodes an SDH protein that exhibits decreased enzymatic activity (for example, via decreased resistance to inhibition of enzyme activity).
- a polynucleotide can be introduced that encodes a protein having SDH enzyme activity, wherein the polynucleotide comprises regulatory elements that provide for decreased expression of the polynucleotide and/or the protein encoded thereby.
- Plants containing the polynucleotide, or progeny thereof, optionally can be screened for decreased expression of Sdh gene and/or SDH protein, or decreased enzymatic activity of the SDH protein, and/or decreased seed or kernel number.
- multiple copies of a polynucleotide encoding a protein with SDH enzymatic activity are introduced into a plant and stably incorporated into the genome of the plant wherein expression of the multiple copies of the polynucleotide results in increased levels of protein having SDH enzymatic activity.
- Embodiments of the invention can preferably provide for expression of a polynucleotide of the invention and any protein encoded thereby in endosperm of a seed or kernel.
- Plants used in the methods of the present invention or resulting from the methods of the invention can also optionally comprise other mutations that impact other phenotypic characteristics, such as seed weight, etc.
- a plant, plant tissue, or plant cell of the invention also comprises one or more mutations described in U.S. Pat. Nos. 5,589,618; 5,650,557; 5,872,216; 6,069,300; 6,403,863; 6,809,235; 7,312,378; 6,184,438; 6,969,783; and 7,173,165.
- the subject invention also concerns materials and methods for modulating sorbitol levels in plants, plant tissue, and plant cells.
- Modulating expression of an Sdh gene can also increase or reduce levels of sorbitol, a sugar alcohol. Changes in sorbitol levels can have diverse effects.
- One example is its unique influence on embryo-forming endosperm callus, where, unlike other carbon sources, sorbitol supports only embryogenic calli (not non-embryogenic calli) (Swedlund and Locy, 1993). This indicates that sorbitol, or some aspect of its use, is able to affect cell division, differentiation, or meristem formation.
- sorbitol and fructose levels that occur with an sdh mutant provide examples of how altered SDH activity can affect balance of its reactants.
- these reactants include not only fructose (a sugar), sorbitol (a sugar alcohol), but also the nucleotides, NAD and NADH. Changes to any of these reactants (either their pool sizes or flux to other reactions) can have consequences on diverse processes.
- Fructose is a known signaling molecule
- sorbitol effects indicate a similar possibility
- NAD/NADH balance is also known to affect redox status and signaling.
- the Sdh gene can be used as a tool to alter the levels, production, or use of these constituents.
- the subject invention also concerns plants, plant tissue, and plant cells of the invention that exhibit increased or decreased expression of an Sdh encoding polynucleotide or the protein encoded by the polynucleotide, or that express a mutant sdh polynucleotide or a mutant sdh enzyme of the invention, or a fragment or variant thereof.
- Plant tissue includes, but is not limited to, seed, scion, and rootstock.
- the plant, plant tissue, or plant cell is Zea mays .
- a plant, plant tissue, or plant cell is a transgenic plant, plant tissue, or plant cell.
- a plant, plant tissue, or plant cell is one that has been obtained through a breeding program.
- the plant, plant tissue, or plant cell is homozygous for a mutant sdh polynucleotide or gene. In another embodiment, the plant, plant tissue, or plant cell is heterozygous for a mutant sdh polynucleotide or gene. The mutant sdh polynucleotide or gene can be provided by the maternal parent and/or the paternal parent.
- a plant, plant tissue, or plant cell of the invention is a hybrid plant, plant tissue, or plant cell obtained from breeding a plant comprising a polynucleotide that encodes a mutant sdh enzyme of the invention with a plant that comprises a polynucleotide that encodes a wild type SDH enzyme.
- a plant of the invention is an inbred line that has been transformed or bred to exhibit increased or decreased expression of an sorbitol dehydrogenase encoding polynucleotide or the protein encoded by the polynucleotide, or that expresses a mutant sdh polynucleotide or a sdh enzyme of the invention.
- a plant, plant tissue, or plant cell of the invention comprising a polynucleotide that provides for increased or decreased expression of an Sdh encoding polynucleotide or the protein encoded by the polynucleotide, or that comprises a mutant sdh polynucleotide or a mutant sdh enzyme of the invention, can also comprise other mutations that impact other phenotypic characteristics, such as seed weight, etc.
- a plant, plant tissue, or plant cell of the invention also comprises one or more mutations described in U.S. Pat. Nos. 5,589,618; 5,650,557; 5,872,216; 6,069,300; 6,403,863; 6,809,235; 7,312,378; 6,184,438; 6,969,783; and 7,173,165.
- the subject invention also concerns an isolated mutant sdh plant gene or polynucleotide, wherein a plant expressing the mutant gene or polynucleotide exhibits decreased levels of SDH enzyme and/or SDH enzymatic activity.
- the mutant sdh-encoding polynucleotide encodes an SDH enzyme with decreased enzymatic activity relative to a non-mutated or wild type SDH enzyme.
- the mutant SDH enzyme comprises the amino acid sequence shown in SEQ ID NO: 1, or a fragment, or variant thereof.
- the polynucleotide encoding SEQ ID NO:1 comprises the nucleotide sequence shown in SEQ ID NO:2 or SEQ ID NO:3, or a fragment or variant thereof.
- a mutant sdh polynucleotide comprises a mutant nucleotide sequence shown in FIG. 14B , or a fragment or variant of the sequence. Allelic variants of mutant sdh genes or polynucleotides are included within the scope of the invention.
- Expression constructs of the invention generally include regulatory elements that are functional in the intended host cell in which the expression construct is to be expressed.
- Regulatory elements include promoters, transcription termination sequences, translation termination sequences, enhancers, and polyadenylation elements.
- expression construct refers to a combination of nucleic acid sequences that provides for transcription of an operably linked nucleic acid sequence.
- operably linked refers to a juxtaposition of the components described wherein the components are in a relationship that permits them to function in their intended manner. In general, operably linked components are in contiguous relation.
- An expression construct of the invention can comprise a promoter sequence operably linked to a polynucleotide sequence encoding a SDH polypeptide of the invention. Promoters can be incorporated into a polynucleotide using standard techniques known in the art. Multiple copies of promoters or multiple promoters can be used in an expression construct of the invention. In a preferred embodiment, a promoter can be positioned about the same distance from the transcription start site in the expression construct as it is from the transcription start site in its natural genetic environment. Some variation in this distance is permitted without substantial decrease in promoter activity. A transcription start site is typically included in the expression construct.
- plant viral promoters such as, for example, a cauliflower mosaic virus (CaMV) 35S (including the enhanced CaMV 35S promoter (see, for example U.S. Pat. No. 5,106,739)) or a CaMV 19S promoter or a cassava vein mosaic can be used.
- CaMV cauliflower mosaic virus
- Other promoters that can be used for expression constructs in plants include, for example, prolifera promoter, Ap3 promoter, heat shock promoters, T-DNA 1âČ- or 2âČ-promoter of A.
- tumefaciens polygalacturonase promoter, chalcone synthase A (CHS-A) promoter from petunia, tobacco PR-1a promoter, ubiquitin promoter, actin promoter, alcA gene promoter, pin2 promoter (Xu et al., 1993), maize Wipl promoter, maize trpA gene promoter (U.S. Pat. No. 5,625,136), maize CDPK gene promoter, and RUBISCO SSU promoter (U.S. Pat. No. 5,034,322) can also be used.
- CHS-A chalcone synthase A
- Tissue-specific promoters for example fruit-specific promoters, such as the E8 promoter of tomato (accession number: AF515784; Good et al. (1994)) can be used.
- Fruit-specific promoters such as flower organ-specific promoters can be used with an expression construct of the present invention for expressing a polynucleotide of the invention in the flower organ of a plant.
- flower organ-specific promoters include any of the promoter sequences described in U.S. Pat. Nos. 6,462,185; 5,639,948; and 5,589,610.
- Seed-specific promoters such as the promoter from a â -phaseolin gene (for example, of kidney bean) or a glycinin gene (for example, of soybean), and others, can also be used.
- Endosperm-specific promoters include, but are not limited to, MEG1 (EPO application No. EP1528104) and those described by Wu et al. (1998), Furtado et al. (2001), and Hwang et al. (2002).
- Root-specific promoters such as any of the promoter sequences described in U.S. Pat. Nos. 6,455,760 or 6,696,623, or in published U.S. patent application Nos.
- 20040078841; 20040067506; 20040019934; 20030177536; 20030084486; or 20040123349 can be used with an expression construct of the invention.
- Constitutive promoters such as the CaMV, ubiquitin, actin, or NOS promoter
- developmentally-regulated promoters such as the CaMV, ubiquitin, actin, or NOS promoter
- inducible promoters such as those promoters than can be induced by heat, light, hormones, or chemicals
- Expression constructs of the invention may optionally contain a transcription termination sequence, a translation termination sequence, a sequence encoding a signal peptide, and/or enhancer elements.
- Transcription termination regions can typically be obtained from the 3âČ untranslated region of a eukaryotic or viral gene sequence. Transcription termination sequences can be positioned downstream of a coding sequence to provide for efficient termination.
- a signal peptide sequence is a short amino acid sequence typically present at the amino terminus of a protein that is responsible for the relocation of an operably linked mature polypeptide to a wide range of post-translational cellular destinations, ranging from a specific organelle compartment to sites of protein action and the extracellular environment.
- Classical enhancers are cis-acting elements that increase gene transcription and can also be included in the expression construct.
- Classical enhancer elements are known in the art, and include, but are not limited to, the CaMV 35S enhancer element, cytomegalovirus (CMV) early promoter enhancer element, and the SV40 enhancer element.
- CMV cytomegalovirus
- Intron-mediated enhancer elements that enhance gene expression are also known in the art. These elements must be present within the transcribed region and are orientation dependent. Examples include the maize shrunken-1 enhancer element (Clancy and Hannah, 2002).
- DNA sequences which direct polyadenylation of mRNA transcribed from the expression construct can also be included in the expression construct, and include, but are not limited to, an octopine synthase or nopaline synthase signal.
- the expression constructs of the invention can also include a polynucleotide sequence that directs transposition of other genes, i.e., a transposon.
- Polynucleotides of the present invention can be composed of either RNA or DNA. Preferably, the polynucleotides are composed of DNA.
- the subject invention also encompasses those polynucleotides that are complementary in sequence to the polynucleotides disclosed herein. Polynucleotides and polypeptides of the invention can be provided in purified or isolated form.
- polynucleotide sequences can encode SDH enzymes useful in the present invention.
- a table showing all possible triplet codons (and where U also stands for T) and the amino acid encoded by each codon is described in Lewin (1985).
- references to âessentially the sameâ sequence refers to sequences which encode amino acid substitutions, deletions, additions, or insertions which do not materially alter the functional activity of the polypeptide encoded by the polynucleotides of the present invention. Allelic variants of the nucleotide sequences encoding an SDH or a mutant sdh of the invention are also encompassed within the scope of the invention.
- amino acids other than those specifically exemplified or naturally present in an SDH or a mutant sdh enzyme of the invention are also contemplated within the scope of the present invention.
- non-natural amino acids can be substituted for the amino acids of an SDH or a mutant sdh enzyme, so long as the SDH or a mutant sdh enzyme having the substituted amino acids retains substantially the same functional activity as the SDH or a mutant sdh in which amino acids have not been substituted.
- non-natural amino acids include, but are not limited to, ornithine, citrulline, hydroxyproline, homoserine, phenylglycine, taurine, iodotyrosine, 2,4-diaminobutyric acid, â -amino isobutyric acid, 4-aminobutyric acid, 2-amino butyric acid, â -amino butyric acid, â -amino hexanoic acid, 6-amino hexanoic acid, 2-amino isobutyric acid, 3-amino propionic acid, norleucine, norvaline, sarcosine, homocitrulline, cysteic acid, â -butylglycine, â -butylalanine, phenylglycine, cyclohexylalanine, â -alanine, fluoro-amino acids, designer amino acids such as O-methyl amino acids, C-methyl amino acids, N
- Non-natural amino acids also include amino acids having derivatized side groups.
- any of the amino acids in the protein can be of the D (dextrorotary) form or L (levorotary) form.
- Allelic variants of a protein sequence of SDH or a mutant sdh enzyme of the present invention are also encompassed within the scope of the invention.
- Amino acids can be generally categorized in the following classes: non-polar, uncharged polar, basic, and acidic. Conservative substitutions whereby an SDH or a mutant sdh enzyme of the present invention having an amino acid of one class is replaced with another amino acid of the same class fall within the scope of the subject invention so long as the SDH or a mutant sdh enzyme having the substitution still retains substantially the same functional activity (e.g., decreased enzymatic activity) as the SDH or a mutant sdh enzyme that does not have the substitution. Polynucleotides encoding an SDH or a mutant sdh enzyme having one or more amino acid substitutions in the sequence are contemplated within the scope of the present invention. Table 1 below provides a listing of examples of amino acids belonging to each class.
- the subject invention also concerns variants of the polynucleotides of the present invention that encode enzymatically active SDH enzymes of the invention.
- Variant sequences include those sequences wherein one or more nucleotides of the sequence have been substituted, deleted, and/or inserted.
- the nucleotides that can be substituted for natural nucleotides of DNA have a base moiety that can include, but is not limited to, inosine, 5-fluorouracil, 5-bromouracil, hypoxanthine, 1-methylguanine, 5-methylcytosine, and tritylated bases.
- the sugar moiety of the nucleotide in a sequence can also be modified and includes, but is not limited to, arabinose, xylulose, and hexose.
- the adenine, cytosine, guanine, thymine, and uracil bases of the nucleotides can be modified with acetyl, methyl, and/or thio groups. Sequences containing nucleotide substitutions, deletions, and/or insertions can be prepared and tested using standard techniques known in the art.
- Fragments and variants of an SDH or a mutant sdh enzyme of the present invention can be generated as described herein and tested for the presence of enzymatic function using standard techniques known in the art.
- an ordinarily skilled artisan can readily prepare and test fragments and variants of an SDH or a mutant sdh enzyme of the invention and determine whether the fragment or variant retains functional enzymatic activity relative to full-length or a non-variant SDH or a mutant sdh enzyme.
- Polynucleotides and polypeptides contemplated within the scope of the subject invention can also be defined in terms of more particular identity and/or similarity ranges with those sequences of the invention specifically exemplified herein.
- the sequence identity will typically be greater than 60%, preferably greater than 75%, more preferably greater than 80%, even more preferably greater than 90%, and can be greater than 95%.
- the identity and/or similarity of a sequence can be 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99% as compared to a sequence exemplified herein.
- the subject invention also contemplates those polynucleotide molecules having sequences which are sufficiently homologous with the polynucleotide sequences exemplified herein so as to permit hybridization with that sequence under standard stringent conditions and standard methods (Maniatis et al., 1982).
- stringent conditions for hybridization refers to conditions wherein hybridization is typically carried out overnight at 20-25 C. below the melting temperature (Tm) of the DNA hybrid in 6 â SSPE, 5 â Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA.
- Tm melting temperature
- Tm 81.5 C+16.6 Log[Na+]+0.41(%G+C)-0.61(% formamide)-600/length of duplex in base pairs.
- Washes are typically carried out as follows:
- nucleic acid and âpolynucleotideâ refer to a deoxyribonucleotide, ribonucleotide, or a mixed deoxyribonucleotide and ribonucleotide polymer in either single- or double-stranded form, and unless otherwise limited, would encompass known analogs of natural nucleotides that can function in a similar manner as naturally-occurring nucleotides.
- the polynucleotide sequences include the DNA strand sequence that is transcribed into RNA and the strand sequence that is complementary to the DNA strand that is transcribed.
- polynucleotide sequences also include both full-length sequences as well as shorter sequences derived from the full-length sequences. Allelic variations of polynucleotide sequences of the invention also fall within the scope of the subject invention.
- the polynucleotide sequence includes both the sense and antisense strands either as individual strands or in the duplex.
- Plants within the scope of the present invention include monocotyledonous plants, such as, for example, rice, wheat, barley, oats, rye, sorghum, maize, sugarcane, pineapple, onion, bananas, coconut, lilies, turfgrasses, and millet.
- monocotyledonous plants such as, for example, rice, wheat, barley, oats, rye, sorghum, maize, sugarcane, pineapple, onion, bananas, coconut, lilies, turfgrasses, and millet.
- Plants within the scope of the present invention also include dicotyledonous plants, such as, for example, tomato, cucumber, squash, peas, alfalfa, melon, chickpea, chicory, clover, kale, lentil, soybean, beans, tobacco, potato, sweet potato, yams, cassava, radish, broccoli, spinach, cabbage, rape, apple trees, citrus (including oranges, mandarins, grapefruit, lemons, limes and the like), grape, cotton, sunflower, strawberry, and lettuce.
- Herb plants containing a polynucleotide of the invention are also contemplated within the scope of the invention.
- Herb plants include parsley, sage, rosemary, thyme, and the like.
- the subject invention also concerns methods for producing a plant that exhibits increased or decreased SDH content and/or enzymatic activity relative to a wild type plant, wherein a polynucleotide encoding an SDH or a mutant sdh enzyme of the present invention is introduced into a plant cell and the polypeptide(s) encoded by the polynucleotide(s) is expressed.
- the polynucleotide or polynucleotides is incorporated into the genome of the plant cell and a plant is grown from the plant cell.
- the plant grown from the plant cell stably expresses the incorporated polynucleotide or polynucleotides.
- the subject invention also concerns methods and materials for selecting for plants having increased or decreased seed size, seed number and/or sugar content.
- a mutant sdh gene or polynucleotide that encodes an SDH enzyme having decreased enzymatic activity relative to a wild type or non-mutated SDH is utilized as a genetic marker.
- the SDH enzyme comprises an amino acid sequence of SEQ ID NO: 1, or a fragment or variant thereof.
- the mutant sdh gene or polynucleotide comprises a nucleotide sequence of SEQ ID NO: 2 or SEQ ID NO: 3, or a mutant sequence shown in FIG. 14B , or a fragment or variant thereof.
- Methods of the invention comprise determining whether a plant, plant tissue, or plant cell contains a mutant sdh gene or polynucleotide of the invention, and/or determining whether a plant, plant tissue, or plant cell comprises or expresses a mutant SDH enzyme of the present invention.
- the presence of a mutant sdh gene or polynucleotide is determined by screening nucleic acid from the plant, plant tissue, or plant cell for hybridization with a nucleic acid probe (e.g., an oligonucleotide of the invention) that hybridizes with a mutant sdh gene or polynucleotide of the invention.
- the presence of a mutant sdh gene or polynucleotide is determined by restriction fragment length polymorphism (RFLP) analysis, by polymerase chain reaction (PCR) amplification of specific sdh nucleic acid sequences, or by sequencing sdh-encoding nucleic acid from the plant, plant tissue, or plant cell and identifying whether the gene or polynucleotide comprises a mutant sequence that provides for decreased sdh mRNA levels or decreased SDH enzymatic activity.
- RFLP restriction fragment length polymorphism
- PCR polymerase chain reaction
- the subject invention also concerns methods for marker assisted selection and breeding in plants using a gene or polynucleotide that provides for modulated expression (increased or decreased) of Sdh or the gene product thereof for selecting for plants, plant tissue, or plant cells that exhibit a phenotypic characteristic of interest, e.g., increased or decreased seed size, seed number, sugar content, etc.
- Methods for marker assisted selection are known in the art.
- a method uses a mutant sdh gene or polynucleotide of the invention that encodes a sorbitol dehydrogenase enzyme that is non-functional or that exhibits decreased enzymatic activity relative to a non-mutant SDH enzyme, or wherein the mutant sdh gene or polynucleotide provides for decreased or no expression of gene transcripts or translation of gene transcripts.
- the subject invention also concerns oligonucleotide probes and primers, such as polymerase chain reaction (PCR) primers, that can hybridize to a coding or non-coding sequence of a polynucleotide of the present invention.
- Oligonucleotide probes of the invention can be used in methods for detecting and quantitating nucleic acid sequences encoding a sorbitol dehydrogenase.
- Oligonucleotide primers of the invention can be used in PCR methods and other methods involving nucleic acid amplification.
- a probe or primer of the invention can hybridize to a polynucleotide of the invention under stringent conditions.
- Probes and primers of the invention can optionally comprise a detectable label or reporter molecule, such as fluorescent molecules, enzymes, radioactive moiety (e.g., 3 H, 35 S, 125 I, etc.), and the like.
- Probes and primers of the invention can be of any suitable length for the method or assay in which they are being employed. Typically, probes and primers of the invention will be 10 to 500 or more nucleotides in length. Probes and primers that are 10 to 20, 21 to 30, 31 to 40, 41 to 50, 51 to 60, 61 to 70, 71 to 80, 81 to 90, 91 to 100 or more nucleotides in length are contemplated within the scope of the invention.
- Probes and primers of the invention can have complete (100%) nucleotide sequence identity with the polynucleotide sequence, or the sequence identity can be less than 100%.
- sequence identity between a probe or primer and a sequence can be 99%, 98%, 97%, 96%, 95%, 90%, 85%, 80%, 75%, 70% or any other percentage sequence identity so long as the probe or primer can hybridize under stringent conditions to a nucleotide sequence of a polynucleotide of the invention.
- a probe or primer of the invention has 70% or greater, 75% or greater, 80% or greater, 85% or greater, 90% or greater, or 95% to 100% sequence identity with a nucleotide sequence of SEQ ID NO: 2 or SEQ ID NO: 3, or the complement thereof.
- the subject invention also concerns an isolated mutant sorbitol dehydrogenase.
- the mutant sorbitol dehydrogenase is a sorbitol dehydrogenase 1 of Zea mays .
- a sorbitol dehydrogenase enzyme of the invention has an amino acid sequence as shown in SEQ ID NO: 1, or an enzymatically active fragment or variant thereof.
- a sorbitol dehydrogenase enzyme of the invention can be purified using standard techniques known in the art.
- a polynucleotide of the invention encoding a sorbitol dehydrogenase is incorporated into a microorganism, such as E. coli , and the sorbitol dehydrogenase expressed in the microorganism and then its protein product isolated therefrom.
- Polypeptides of the invention can be used to generate antibodies that bind specifically to a polypeptide of the invention, and such antibodies are contemplated within the scope of the invention.
- the antibodies of the invention can be polyclonal or monoclonal and can be produced and isolated using standard methods known in the art.
- Polypeptide fragments according to the subject invention typically comprise a contiguous span of about or at least 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119,
- Polypeptide fragments of the subject invention can be any integer in length from at least about 25 consecutive amino acids to 1 amino acid less than the sequence shown in SEQ ID NO: 1.
- a polypeptide fragment can be any integer of consecutive amino acids from about 25 to 365 amino acids.
- integer is used herein in its mathematical sense and thus representative integers include: 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120,
- Each polypeptide fragment of the subject invention can also be described in terms of its N-terminal and C-terminal positions. For example, combinations of N-terminal to C-terminal fragments of about 25 contiguous amino acids to 1 amino acid less than the full length polypeptide of SEQ ID NO: 1 are included in the present invention.
- a 25 consecutive amino acid fragment could correspond to amino acids of SEQ ID NO: 1 selected from the group consisting of 1-25, 2-26, 3-27, 4-28, 5-29, 6-30, 7-31, 8-32, 9-33, 10-34, 11-35, 12-36, 13-37, 14-38, 15-39, 16-40, 17-41, 18-42, 19-43, 20-44, 21-45, 22-46, 23-47, 24-48, 25-49, 26-50, 27-51, 28-52, 29-53, 30-54, 31-55, 32-56, 33-57, 34-58, 35-59, 36-60, 37-61, 38-62, 39-63, 40-64, 41-65, 42-66, 43-67, 44-68, 45-69, 46-70, 47-71, 48-72, 49-73, 50-74, 51-75, 52-76, 53-77, 54-78, 55-79, 56-80, 57-81, 58
- amino acids corresponding to all other fragments of sizes between 26 consecutive amino acids and 365 consecutive amino acids of SEQ ID NO: 1 are included in the present invention and can also be immediately envisaged based on these examples. Therefore, additional examples, illustrating various fragments of the polypeptides of SEQ ID NO: 1 are not individually listed herein in order to avoid unnecessarily lengthening the specification.
- Polypeptide fragments comprising: 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124,
- c is an integer between 25 and the number of amino acids of the full length polypeptide sequence (366 for SEQ ID NO: 1) and ânâ is an integer smaller than âcâ by at least 24.
- n is any integer selected from the list consisting of: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111,
- Fragments of a sorbitol dehydrogenase of the invention can be obtained by cleaving the polypeptides of the invention with a proteolytic enzyme (such as trypsin, chymotrypsin, or collagenase) or with a chemical reagent, such as cyanogen bromide (CNBr).
- a proteolytic enzyme such as trypsin, chymotrypsin, or collagenase
- CNBr cyanogen bromide
- polypeptide fragments can be generated in a highly acidic environment, for example at pH 2.5.
- Polypeptide fragments can also be prepared by chemical synthesis or using host cells transformed with an expression vector comprising a polynucleotide encoding a fragment of a sorbitol dehydrogenase enzyme of the invention, for example, a sorbitol dehydrogenase that is a fragment of the amino acid sequence shown in SEQ ID NO: 1.
- the subject invention also concerns cells transformed with a polynucleotide of the present invention encoding a sorbitol dehydrogenase of the invention.
- the cell is transformed with a polynucleotide sequence comprising a sequence encoding the amino acid sequence shown in SEQ ID NO: 1, or an enzymatically active fragment or variant thereof.
- the cell is transformed with a polynucleotide sequence shown in SEQ ID NO: 2 or 3, or a sequence encoding an enzymatically active fragment or variant of SEQ ID NO:1.
- a mutant sdh polynucleotide comprises a mutant nucleotide sequence shown in FIG. 14B , or a fragment or variant of the nucleotide sequence.
- the polynucleotide sequence is provided in an expression construct of the invention.
- the transformed cell can be a prokaryotic cell, for example, a bacterial cell such as E. coli or B. subtilis , or the transformed cell can be a eukaryotic cell, for example, a plant cell, including protoplasts, or an animal cell.
- Plant cells include, but are not limited to, dicotyledonous, monocotyledonous, and conifer cells.
- the plant cell is a cell from a Zea mays plant.
- Animal cells include human cells, mammalian cells, avian cells, and insect cells. Mammalian cells include, but are not limited to, COS, 3T3, and CHO cells.
- an âantisenseâ nucleic acid sequence can include a nucleotide sequence that is complementary to a âsenseâ nucleic acid sequence encoding a protein, e.g., complementary to the coding strand of a double-stranded cDNA molecule or complementary to at least a portion of an Sdh gene.
- the antisense nucleic acid sequence can be complementary to an entire coding strand of a target sequence, or to only a portion thereof.
- the antisense nucleic acid molecule is antisense to a ânoncoding regionâ of the coding strand of a nucleotide sequence within the gene.
- An antisense oligonucleotide can be, for example, about 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, or more nucleotides in length.
- An antisense nucleic acid sequence can be designed such that it is complementary to the entire gene, but can also be an oligonucleotide that is antisense to only a portion of the gene.
- the antisense oligonucleotide can be complementary to the region surrounding the translation start site of the target mRNA, e.g., between the â 10 and +10 regions of the target gene nucleotide sequence of interest.
- an antisense nucleic acid sequence of the invention can be constructed using chemical synthesis and enzymatic ligation reactions using procedures known in the art.
- an antisense nucleic acid e.g., an antisense oligonucleotide
- an antisense nucleic acid can be chemically synthesized using naturally occurring nucleotides or variously modified nucleotides designed to increase the biological stability of the molecules or to increase the physical stability of the duplex formed between the antisense and sense nucleic acids, e.g., phosphorothioate derivatives and acridine substituted nucleotides can be used.
- the antisense nucleic acid sequence also can be produced biologically using an expression vector into which a nucleic acid sequence has been subcloned in an antisense orientation (i.e., RNA transcribed from the inserted nucleic acid sequence will be of an antisense orientation to a target nucleic acid sequence of interest, described further in the following sub section).
- Ribozymes are a type of RNA that can be engineered to enzymatically cleave and inactivate other RNA targets in a specific, sequence-dependent fashion. By cleaving the target RNA, ribozymes inhibit translation, thus preventing the expression of the target gene. Ribozymes can be chemically synthesized in the laboratory and structurally modified to increase their stability and catalytic activity using methods known in the art. Alternatively, ribozyme encoding nucleotide sequences can be introduced into cells through gene-delivery mechanisms known in the art.
- a ribozyme having specificity for Sdh RNA can include one or more sequences complementary to the nucleotide sequence of at least a portion of one or more Sdh mRNA, and a sequence having known catalytic sequence responsible for mRNA cleavage (see U.S. Pat. No. 5,093,246 or Haselhoff et al. 1988).
- a derivative of a Tetrahymena L-19 IVS RNA can be constructed in which the nucleotide sequence of the active site is complementary to the nucleotide sequence to be cleaved in the Sdh mRNA (see, e.g., U.S. Pat. Nos. 4,987,071; and 5,116,742).
- Sdh mRNA encoding an Sdh protein can be used to select a catalytic RNA having a specific ribonuclease activity from a pool of RNA molecules (see, e.g., Bartel et al. 1993).
- RNA interference refers to a selective intracellular degradation of RNA. RNAi occurs in cells naturally to remove foreign RNAs (e.g., viral RNAs). Natural RNAi proceeds via fragments cleaved from free dsRNA which direct the degradative mechanism to other similar RNA sequences. Alternatively, RNAi can be initiated by the hand of man, for example, to silence the expression of target genes.
- siRNA short interfering RNA
- siRNA refers to an RNA (or RNA analog) comprising between about 10-50 nucleotides (or nucleotide analogs) which is capable of directing or mediating RNA interference.
- RNAi target-specific RNA interference
- mRNA messenger RNA
- transcription each refer to single-stranded RNA that specifies the amino acid sequence of one or more polypeptides. This information is translated during protein synthesis when ribosomes bind to the mRNA.
- Sdh1 Sorbitol dehydrogenase-1 gene
- An sdh1 mutant was isolated from the Uniform-Mu maize population by screening the Reverse-Genetics Grids with gene-specific probes and primers.
- the Mu insertion was at the far 5âČ end of the sdh1 gene, immediately upstream of the start site ( FIG. 8 ).
- the first of these is the uniform background, which is invaluable for comparisons to wildtype controls.
- the high degree of genetic similarity results from 9 generations of back-crossing to the W22 inbred (McCarty et al., 2005).
- the second advantage is the low mutant-load from previous generations, due to continual removal of any mutations, and repeated back-crossing to the inbred.
- the sdh1 mutant has been backcrossed 2 additional times. This maximizes the probability of a causal linkage between the observed phenotype and the sdh1 mutation.
- a third advantage is a capacity to fully-stabilize new mutants by selecting those lacking a functional transposase gene (using a color marker), and this has been completed for the sdh1 mutant.
- FIG. 9 shows both the reduced size of sdh1 kernels and their deficiency in SDH activity (the latter by in situ activity stain and quantified assays). Maximal activity of SDH from mutant kernels remained less than 6% of that from wildtype. Dried-seed weight of sdh1 kernels was 21% less than that of wildtype (p â 0.001 from first-year greenhouse and field studies) ( FIG. 10 ). No differences were detectable between wildtype and heterozygous kernels although levels of Sdh1 mRNA were approximately 30% less (not shown). Similar results were observed when kernel size was compared on sdh1 and wildtype ears selected for similar overall kernel numbers.
- a particularly interesting contribution by the sdh mutation to kernel number is its effect on numbers of rows per ear, which increased an average of 25% for sdh mutant females ( FIG. 13C ). This was unexpected because row number is determined early in floral development, much before pollination, and prior to previously-detected expression of the Sdh1 gene (de Sousa et al., in preparation). Since the sdh mutation alters floral architecture more than 12 days before pollination, it must do so in minute primordial tissues of the newly-forming flower, where changes in gene expression could initially have been missed. The site and timing of this effect is also unexpected for a metabolic enzyme, but examples are emerging in maize and other systems for often-surprising contributions by sugar metabolism to changes in development.
- Examples include the influence of trehalose phosphate on floral architecture and other developmental features (Grennan, 2007), contributions by sugar pulses to induction of flowering in the apical meristem (Bernier and Perilleux), and complex effects of sugar metabolism on expression of genes for growth and development (Koch, 1996; Ohto et al., 2001; and Koch, 2004).
- FIGS. 14 and 15 indicate a link between effects of a dysfunctional sdh1 gene and its role in hybrid vigor of maize.
- the âwildtypeâ sdh1 gene in the widely-used B73 inbred is actually a naturally-occurring sdh1 mutant If this sdh1 has limited function (as predicted by the site of its insert (see below) and data not shown), then this mutation may contribute significantly to the âcombining abilityâ of B73 for hybrid corn production by increasing the number of kernels available for filling.
- FIG. 14A shows the site of transposon inserts in the different sdh1 mutant genes.
- FIG. 14B compares the sequence of the B73 sdh1 mutant gene to that of a wildtype Sdh1 gene from a W22 inbred.
- the insert into the B73 gene is about 100kb long and has characteristic features of a small transposable element (terminal inverted repeats at each end of the inserted sequence).
- the âwildtypeâ Sdh1 sequence available from GenBank is the mutated B73 sdh allele shown in FIG. 14B . Its mutant status was not evident until it was compared to a true wildtype gene lacking the transposable element disruption to its sequence.
- FIG. 15 Further evidence for dysfunction of a mutant sdh1 gene is shown in FIG. 15 .
- Sorbitol dehydrogenase 1 gene expression is reduced to barely detectable mRNA levels throughout development of kernels from the B73 inbred, but not for those of the W22 inbred with its intact Sdh1 sequence.
- the B73 inbred has long been known for phenotypic features that resemble those conferred by the sdh1 mutant gene. These include a large number of somewhat smaller seeds, and a shorter, wider ear. These characters also appear to have contributed to the strength of B73 as a combinatorial partner in hybrid maize.
- FIG. 16 shows higher levels of sucrose, glucose, and fructose in sdh1-mutant kernels when these are compared to wildtype kernels at stages of development when sweet corn is typically harvested. Differences are not evident at kernel maturity, but persist during the sweet-corn harvest period (about 20 to 25 days after pollination (DAP)). Glucose and fructose, in particular, are about 2-fold greater in sdh1-than in wildtype kernels at 25 days after pollination (DAP).
- DAP days after pollination
- the possible usefulness of altered sdh1 expression in sweet corn lines is compatible with the observed up-regulation of this gene by sugars (noted earlier in FIGS. 6A and 6B ) and in other, currently used sweet-corn lines (shown earlier for the shrunken2, sweet-corn mutant in FIG. 7 ).
- FIG. 17 shows that the sdh1 mutant kernels have reduced starch levels at maturity (about 25% less). Starch reductions are typical of sweet-corn mutations, but the level of starch remaining here (and available for seed germination) is considerably greater than for most sweet corn lines. Protein content and zein composition of sdh1 kernels remained similar to those of wildtype kernels.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Environmental Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Botany (AREA)
- Physiology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Description
- The present application is a continuation of U.S. application Ser. No. 12/599,652, filed Nov. 5, 2010, which is the National Stage of International Application Number PCT/US2008/064130, filed May 19, 2008, which claims the benefit of U.S. Provisional Application Serial No. 60/930,803, filed May 18, 2007, and U.S. Provisional Application Serial No. 60/958,605, filed Jul. 6, 2007, each of which is hereby incorporated by reference herein in its entirety, including any figures, tables, nucleic acid sequences, amino acid sequences, and drawings.
- This invention was made with government support under CAPES Brazil, the USDA-CSREES-National Research Initiative, and the National Science Foundation, USA; CAPES project number 0083062, USDA project number 35318-18394. The government has certain rights in the invention.
- Sorbitol is a primary end-product for photosynthesis and a major carbohydrate translocated by many economically-important fruit trees. These are mainly members of two Rosaceaeous subfamilies (Pomoideae and Prunoideae), and include apple, pear, peach, cherry, apricot, and plum (Bieleski and Redgwell, 1985; Loescher and Everard, 1996; Oura et al., 2000). Both sorbitol and sucrose are transported from source leaves to sink tissues such as fruit and shoot tips (Bieleski, 1982; Loescher, 1987). In these species, sorbitol accounts for 50-90% of the C fixed and exported from source leaves (Webb and Burley, 1962; Bieleski and Redgwell, 1985). Sorbitol synthesis shares a common hexose-phosphate pool with sucrose synthesis in the cytosol. In source leaves, G6P is first converted to sorbitol 6-phosphate by aldose 6-phosphate reductase (A6PR; EC 1.1.1.200, also called sorbitol-6-phosphate dehydrogenase, S6PDH), followed by hydrolysis of sorbitol 6-phosphate to form sorbitol via sorbitol-6-phosphate phosphatase (SorPP; EC 3.1.3.50). In these systems, A6PR catalyzes the key regulatory step in sorbitol synthesis (Negm and Loescher 1981; Zhou et al., 2003; Park et al., 2002; Yamada et al., 1998).
- When sorbitol is transported to sink tissues of apple or related species, it is converted to fructose by sorbitol dehydrogenase (SDH) prior to further metabolism. Sorbitol dehydrogenases are active in plants, animals, and microorganisms (Touster and Shaw 1962; Bieleski, 1982). The enzyme was first purified from rat liver (Blakley, 1951), and has since been purified and characterized from many sources (Maret and Auld, 1988; Ng et al., 1992; Yamagushi et al., 1994; Marini et al., 1997). In plants, SDH was partially purified and characterized from apple callus (Negm and Loescher, 1979) and maize kernels (Doehlert, 1987), followed by subsequent purification from apple fruits (Yamagushi et al., 1994). SDH activity is high in young apple leaves (Loescher et al., 1982), peach leaves (Merlo and Passera, 1991), and in shoot apecies of peach (Lo Bianco et al., 1999a, Lo Bianco et al., 1999b). In these species, SDH is considered a good indicator of sink strength, which is consistent with its active expression in developing apple fruit (Nosarszewski et al., 2004). In sink tissues of apple, levels of SDH mRNAs can also be enhanced by exogenous feeding of sorbitol (Archbold, 1999; Lida et al., 2004; Zhou et al. 2006). Recently, SDH activity was successfully decreased in transgenic apple trees silenced for sorbitol-6-phosphate dehydrogenase (Teo et al., 2005). This change affected fruit quality and also altered long-distance partitioning. An antisense strategy was also used to reduce activity of A6PR, which lowered sorbitol levels in source leaves and increased those of sucrose (Cheng et al., 2005). An additional consequence of this change was a down-regulation of SDH in assimilate-importing shoot tips, and a commensurate up-regulation of sucrose synthase (Zhou et al., 2006).
- Sorbitol may also share some functions with other sugar-alcohols. Mannitol, for example has been proposed to function in dissipation of excess reducing power during photosynthesis by celery (Loescher, 1987). This was considered a possible contributor to the unusual photosynthetic features of this plant. Other roles for sugar alcohols have included their function as protectants against osmotic, ionic, and temperature stress (Everard et al., 1994; Noiraud et al., 2000). An intriguing role for sorbitol has also been implicated by studies of in vitro development of somatic maize embryos, where sorbitol was found to be unique among different sugars in its capacity to support growth of embryogenic callus (Swedlund and Locy, 1993).
- In maize, the roles of sorbitol remain unclear. It does not appear to have a long-distance transport function, since sorbitol levels are below detection in maize phloem (Zimmerman and Ziegler, 1975). In addition, although sorbitol can be abundant in developing kernels (Carey, 1982; Doehlert and Kuo, 1990), levels drop as the grains mature. Any osmo-protective roles of sorbitol in kernels would thus be limited to periods prior to onset of desiccation tolerance. Nonetheless, significant amounts of photosynthate are partitioned to sorbitol as assimilates enter kernels (Shaw and Dickinson, 1984).
- The role of sorbitol dehydrogenase in maize has remained likewise equivocal. Collective evidence suggests that in vivo, SDH activity in the maize kernel may operate in an opposite direction to that observed in sink tissues of apple and related species. Sucrose first arriving at the kernel can be cleaved by either invertase or the reversible sucrose synthase reaction. In either case, fructose is a product (Koch, 2004). Fructose is typically phosphorylated by hexokinase, then used for respiration or polysaccharide biosynthesis. Alternatively, fructose may follow a less well-known fate in kernels, where it can be converted to sorbitol by sorbitol dehydrogenase (SDH, EC 1.1.1.14). SDH is highly active in maize endosperm, but since kernels do not store sorbitol, an intermediary role seems likely. The Km and Vmax of maize sorbitol dehydrogenase (Km [fructose] 136 mM and Km [sorbitol] 8.45 mM; Doehlert, 1987) would favor sorbitol biosynthesis in high-fructose tissues. Also, a negative correlation has been reported between fructose abundance and SDH activity in maize kernels (Doehlert and Kuo, 1990). The preferred direction of SDH will depend largely on the ratio of (fructose+NADH) to (sorbitol+NAD), however, so high NADH content will also favor sorbitol formation.
- Relevant to this issue are recent analyses showing very low oxygen levels inside maize kernels (
FIG. 1 [from Rolletschek et al., 2005]). Oxygen percentages drop to the level of detection, or below, immediately inside the endosperm. Such an environment has important implications for deposition of protein and starch. The latter remains unaffected, even when exogenous oxygen levels are further depleted (Rolletshek et al., 2005). Although partitioning of photosynthate to embryo lipids requires more oxygen, endosperm biochemistry appears well adapted to its low-oxygen environment. Plant glycolysis is especially versatile in this regard (Plaxton and Podesta, 2006; Koch 2004; Huber and Akazawa, 1986), but supplies of NAD could become limiting under low-O2 conditions. Elevated NADH levels in the maize endosperm would favor a sorbitol-producing role for SDH and its potential dissipation (or balance) of excess reducing power. Any short-distance movement of sorbitol to better-oxygenated areas, such as embryos, could facilitate generation of NADH and fructose for use at those sites. Other endosperm regions may also be locales of sorbitol use, since metabolic gradients in this structure can be marked (Rolletschek et al., 2005). - Work from sorbitol-transporting species has identified a number of sorbitol-handling enzymes, which we have sought in the maize and rice genomes, and tested at the activity level in maize. Our preliminary work has identified an aldose reductase (AR, EC 1.1.1.21) that that may be a candidate for sorbitol degradation in kernels. This AR appears to prefer sorbitol to glucose as a substrate (not shown), hence may have a sorbitol-degrading role. We also found that the SDH enzyme in maize shares a 67% identity with that in apple. However, the maize and rice genomes lack any genes or proteins with sequence similarity to the apple sorbitol-6-phosphate phosphatase or aldose-6-phosphate reductase. Sequence similarities were also lacking for any maize or rice genes that might encode apple-like enzymes of NADP-dependent sorbitol dehydrogenase (converts sorbitol to glucose), an NADP-dependent sorbitol 6-P dehydrogenase (converts sorbitol 6-P to glucose 6-P), or a sorbitol oxidase (converts sorbitol to glucose independent of either NAD or NADP). We did identify a maize aldose reductase (noted above) that we assayed for capacity to convert sorbitol to glucose, and vice-versa (as occurs in mammals and fungi). This AR shares a 40% identity with aldose-6-phosphate reductase, thus indicating an overall family relationship, but potentially very different enzymes. Bioinformatic analysis of the maize Sdh1 gene indicates that it is present as a single copy in the maize genome (Southern blot results not shown), with a single counterpart in rice (chromosome 8), and Arabidospis (chromosome 5).
- The subject invention concerns materials and methods for modulating seed size in plants. In one embodiment, seed size is decreased relative to wild type seed by inhibiting or knocking out expression of a sorbitol dehydrogenase (Sdh) gene or the gene product thereof. In another embodiment, seed size is increased relative to wild type seed by increasing expression of an Sdh gene or the gene product thereof. In a specific embodiment, an Sdh gene is overexpressed.
- The subject invention also concerns materials and methods for modulating seed number in plants. In one embodiment, seed number is increased relative to wild type seed by inhibiting or knocking out expression of a sorbitol dehydrogenase (Sdh) gene or the gene product thereof. In another embodiment, seed number is decreased relative to wild type seed by increasing expression of an Sdh gene or the gene product thereof. In a specific embodiment, an Sdh gene is overexpressed.
- The subject invention concerns materials and methods for modulating seed sugar content in plants. In one embodiment, seed sugar content is increased relative to wild type seed by inhibiting or knocking out expression of a sorbitol dehydrogenase (Sdh) gene or the gene product thereof. In another embodiment, seed sugar content is decreased relative to wild type seed by increasing expression of an Sdh gene or the gene product thereof. In a specific embodiment, an Sdh gene is overexpressed.
-
FIG. 1 shows oxygen levels drop to limits of detection or below in endosperm, but not embryos of maize kernels at 300mg FW. Oxygen microprope path is shown along the x axis. (Figure adapted from Rolletshek et al. 2005). Implications for kernel metabolism are profound. -
FIG. 2 shows sites of Sorbitol dehydrogenase-1 expression at the level of Sdh1 mRNA (upper panel) and SDH activity (lower panel), with Etbr loading controls in the mid panel. A 400-bp Sdh1 probe was used for RNA gel blot analyses. Activity assays in native PAGE were conducted with reaction buffer containing 68 mM sorbitol, 0.15 mM NAD, 0.18 mM nitro blue tetrazolium, 0.06 mM phenazine methasulfate, and 50 mM Tris-HCl, pH 8.0. -
FIG. 3 shows SDH activity that was histochemically localized in longitudinally bisected fresh kernels (2 shown) at 20 DAP. One half of each kernel was exposed to reaction buffer with sorbitol for A & B, whereas sorbitol was omitted for control halves C & D. Blue color denotes activity. -
FIGS. 4A-4B show possible scenarios for metabolic roles of sorbitol in maize kernels.FIG. 4A shows a mostly-hypothetical model for whole kernels, but the first portion (role of SDH) can now be tested. Also, preliminary evidence is consistent with sorbitol transfer from endosperm to embryo (seeFIG. 5 and text).FIG. 4B shows how the reversible SDH reaction could also contribute to metabolic cycling with the potential to aid balance of key reactants and/or shuttle them from one site to another. This possibility would include control of pool sizes for potential signaling molecules (like fructose) or redox control (as for NAD/NADH), and could operate in tissues other than seeds (e.g., floral apecies). -
FIGS. 5A-5F show maize embryos (14 DAP) grown in MS (4.3 g/l) salts for 7 days with or without the following supplements.FIG. 5A : MS alone,FIG. 5B : sorbitol (87.65 mM),FIG. 5C : mannitol (87.65 mM),FIG. 5D : sucrose (87.65 mM),FIG. 5E : glucose (87.65 mM), andFIG. 5F : fructose (87.65 mM). -
FIGS. 6A-6B show sucrose effects on levels of Sdh1 mRNA and SDH enzyme activity inmaize kernels 8 hours after ear injections of sucrose at levels shown.FIG. 6A shows an RNA gel blot with a 400 pb SDH probe. An EtBr control is shown in the lower panel.FIG. 6B shows activity of SDH in sample fractions from the same maize kernels assayed at 30° C., pH 9.0, and 2 mM NAD. -
FIG. 7 shows elevated expression of Sorbitol dehydrogenase-1 (Sdh1) in the shrunken2 âsweet cornâ mutant. RNA gel blot analysis during kernel development (15, 20 and 25 DAP) using a 400 pb SDH probe and showing an EtBr control. -
FIG. 8 shows a Mu insert in an sdh1 (Sorbitol dehydrogenasel) gene from a mutant isolated using the Uniform-Mu MaizeReverse Genetics Grid 1. Two points of intersection were observed. The sdh1 mutant was isolated from one, and the other is probably a related line. DNA traced to Plant 02S-1032-04. -
FIGS. 9A-9B show in situ activity of SDH in maize kernels (25 DAP)FIG. 9A : A. wild type and B. sdh1-mutant kernels incubated with reaction buffer (68 mM sorbitol, 0.15 mM NAD, 0.18 mM nitro blue tetrazolium, 0.06 mM phenazine methasulfate and 50 mM Tris-HCl, pH 8.0). C. wild type and D. sdh1-mutant control reactions incubated with reaction buffer minus sorbitol. Magnified 0.8Ă.FIG. 9B shows activity of sorbitol dehydrogenase enzyme in wild type and sdh1 maize kernels during endosperm development (10, 15, 20 and 25 DAP) assayed at 30° C., pH 9.0, and 2 mM NAD. Error bars are SEMs of 3 replications. -
FIG. 10A shows maize ears and kernels of wildtype (left) and sdh1-mutant plants (right). Kernels were magnified 0.8Ă. InFIG. 10B , dried-seed weight is shown for wildtype and sdh1-mutant kernels, all at 12% moisture (g). Additional results (not shown) were similar for subsequent studies of field- and greenhouse-grown plants (sdh1 kernels consistently 18 to 21% smaller). -
FIG. 11 shows total kernels per ear on wild-type (wt) (shaded bar) and sdh mutant plants (unshaded bar) in an inbred W22 background. Plants were grown in 30-L containers under 12-h, light-supplemented greenhouse conditions (November-January) in Gainesville, Fla. Totals for wt and sdh mothers (**) differed at the 0.2% level p<0.002), with error bars denoting SEMs. Plant genotypes were verified by PCR. Similar results (not shown) were obtained from subsequent analyses of field-grown plants. -
FIG. 12A shows total kernels per ear on wild-type (wt) (shaded bars) and sdh mutant plants (unshaded bars) in an inbred W22 background. Effects of male and female parents are shown as contributions from wild-type (wt) and sdh mutant plants to crosses (denoted at figure base). Similar results (not shown) were obtained from subsequent analyses of field-grown plants.FIG. 12B shows weight of dried ears from the same individuals sampled for kernel number inFIG. 12A . Plants were grown in 30-L containers under 12-h, light-supplemented greenhouse conditions (November-January) in Gainesville, Fla. Means (bars) marked with letters a, b, and c were significantly different at the 3% level (p<0.028), and âaâ differed from âcâ at the 0.01% level (p<0.0001). Totals for wt and sdh mothers (**) differed at the 0.2% level (p<0.002), with error bars denoting SEMs. All genotypes were verified by PCR. Similar results (not shown) were obtained from subsequent analyses of field-grown plants. -
FIGS. 13A-13D show mutant and maternal effects on ear features of (wt) (shaded bars), Sdh mutant plants (unshaded bars), in an inbred W22 background. Bars at the left of each panel compare ears from all wt females to those of all sdh mutant females regardless of the pollen parent utilized (wt or sdh).FIG. 13A shows kernels per ear;FIG. 13B shows kernels per row;FIG. 13C shows rows per ear, andFIG. 13D shows ear length. Plants were grown in 30-L containers under 12-h, light-supplemented greenhouse conditions (November-January) in Gainesville, Fla. Totals for wt and sdh mothers (**) differed at the 0.2% level (p<0.002) for kernels per ear, at the 0.3% level (p<0.0027) for kernels per row, and at the 2% level (p<0.02) for rows per ear. Error bars denote SEMs. All genotypes were verified by PCR. Similar results (not shown) were obtained from subsequent analyses of field-grown plants. -
FIGS. 14A-14B show mutant sdh1 genes in B73 and W22 inbreds.FIG. 14A is a diagram of insert sites for currently-known transposon-induced mutations in sdh1 genes. The W22 mutations have Mu-transposons inserted immediately upstream or downstream of the putative transcription start site (-17 bp for a newly-identified sdh1-2 allele, and +90 bp for the sdh1-1 allele (data in Figures were obtained for the sdh1-1 allele)). Thus far, wildtype Sdh1 sequences are available only from W22 and other non-B73 lines, because theB73 âwildtypeâ gene (entered into the maize genome as such) is actually a mutant that has a transposon residing at â140 bp relative to the putative transcription start site. Evidence indicates that the W22-sdh1-1 mutation decreases gene function to below detectable levels, and initial results from the B73 allele suggest at least partial dysfunction of its sdh1 gene.FIG. 14B is a comparison of the 5âČ sequence from the wildtype Sdh1 (Sorbitol dehydrogenase 1) gene of W22 to that of the âwildtypeâ sdh1 of B73. The B73 sdh1 sequence is shown on the upper line (SEQ ID NO:4), with a portion of the wildtype W22 Sdh1 sequence immediately below it (SEQ ID NO:5). The consensus sequence (SEQ ID NO:6) appears on the third line, and red denotes identical sequences. The transposon insert in the B73 sdh1 gene is shown in black between bp positions 588 and 712. The W22 sdh1-1 and sdh1-2 insert sites would lie at positions 942 and 834, respectively (triangles). The putative transcription start site is at position 852 (arrow), and the translation start site is at 1032 (not shown). -
FIG. 15 shows Sdh1 (Sorbitol dehydrogenase 1) expression at the mRNA level during development of B73 (open squares) and W22 (solid triangles) kernels. -
FIG. 16 shows elevated levels of sucrose, glucose, and fructose in sdh1 mutant kernels when compared to wildtype kernels at stages of development when sweet corn is typically harvested (between 20 and 25 DAP). For mature kernels, dried-seed weight was measured at 12% moisture (g). Error bars show SEMs of 3 biological replications. Soluble sugars were extracted three times from each sample using 80% ethanol (with xylose added as an internal control) at 80° C., and eluted with water. A 50-ul sample was injected into a Waters 2410 HPLC equipped with an refractive index detector. The sugars were separated on a Bio-Rad HPX-87C carbohydrate column. -
FIG. 17 shows kernel starch (g 100gâ1 kernel) and zein content in wildtype and sdh1-mutant kernels. The sdh1 mutant kernels have about 25% less starch than wildtype at maturity. Both sdh1 and wildtype kernels have similar zein content and total protein (wt: 336.26±28.85; sdh1: 404.37±39.96). Dried seed weight of kernels was measured at 12% moisture (g). Error bars are SEMs of 3 replications. - SEQ ID NO: 1 is an amino acid sequence of a
mutant sorbitol dehydrogenase 1 enzyme that can be used according to the present invention. - SEQ ID NO: 2 is a nucleotide sequence that includes a coding region that encodes the amino acid sequence of SEQ ID NO: 1.
- SEQ ID NO: 3 is a nucleotide sequence that encodes the amino acid sequence of SEQ ID NO: 1.
- The subject invention concerns materials and methods for modulating seed size in plants. In one embodiment, seed size is decreased relative to wild type seed by inhibiting or knocking out expression of a Sorbitol dehydrogenase (Sdh) gene or the gene product thereof, or a gene linked to the Sdh gene or the expression thereof. Any means for inhibiting or knocking out expression of a Sdh gene or gene product, or a gene linked thereto, is contemplated within the scope of the present invention. For example, Sdh expression can be inhibited using antisense, short interfering RNA (siRNA), or ribozyme technologies. In one embodiment, Sdh expression can be inhibited in a plant by incorporating a polynucleotide into the plant that provides for an oligonucleotide that is antisense to at least a portion of a nucleotide sequence of an Sdh polynucleotide. In another embodiment, Sdh expression can be inhibited in a plant by incorporating a polynucleotide into the plant that provides for a siRNA molecule capable of directing or mediating RNA interference (RNAi) of Sdh expression. In a further embodiment, Sdh expression can be inhibited in a plant by incorporating a polynucleotide into the plant that encodes a ribozyme that cleaves or inactivates an Sdh RNA.
- In a further embodiment, a mutant sdh-encoding polynucleotide is introduced into the genome of a target plant. In one embodiment, the mutant sdh-encoding polynucleotide encodes a mutant sorbitol dehydrogenase enzyme with decreased enzymatic activity relative to a non-mutated or wild type SDH enzyme. In a specific embodiment, the mutant sorbitol dehydrogenase enzyme comprises the amino acid sequence shown in SEQ ID NO:1, or a fragment, or variant thereof. In one embodiment, the polynucleotide encoding SEQ ID NO:1 comprises the nucleotide sequence shown in SEQ ID NO:2 or SEQ ID NO:3, or a fragment or variant thereof. In another embodiment, a mutant sdh polynucleotide comprises a mutant nucleotide sequence shown in
FIG. 14B , or a fragment or variant thereof. In a further embodiment, a mutant sdh gene is incorporated into the genome of a target plant wherein the mutant sdh gene exhibits decreased or no expression of gene transcripts or translation thereof. In one embodiment, a mutation is introduced into an Sdh gene of a plant that results in decreased transcription of the Sdh gene, or decreased translation of sorbitol dehydrogenase mRNA, and/or that results in a protein exhibiting decreased sorbitol dehydrogenase enzymatic activity. In one embodiment, a mutation is introduced in the Sdh gene upstream of the transcription start site and/or downstream of the transcription start site. In one embodiment, a mutation is introduced into or near a regulatory sequence of an Sdh gene, e.g., in a promoter sequence. The mutation may block or inhibit transcription of the Sdh gene sequence, e.g., by blocking or inhibiting binding of transcription factors or polymerase to the Sdh nucleic acid sequence. In a specific embodiment, a mutation is introduced in the protein coding region of the Sdh gene. Mutations include one or more nucleotide(s) insertions, deletions, or substitutions. Methods for introducing mutations are known in the art. - In another embodiment, seed size is increased relative to wild type seed by increasing expression of an Sdh gene or the gene product thereof, or a gene linked to the Sdh gene or the expression thereof. In a specific embodiment, an Sdh gene is overexpressed. Overexpression of Sdh can be achieved using any number of means known in the art and all such means are contemplated within the scope of the invention. For example, a plant can be transformed with multiple copies of a polynucleotide encoding Sdh. In another embodiment, a plant can be transformed with a polynucleotide encoding Sdh, wherein the polynucleotide comprises a promoter and/or other regulatory sequences that provide for increased expression of the polynucleotide, or the Sdh gene product.
- In one embodiment, a method of the invention comprises introducing or incorporating a polynucleotide into a plant wherein the polynucleotide or the expression product thereof provides for increased expression of Sdh gene or SDH protein relative to a plant wherein the polynucleotide has not been introduced (e.g., a wild type plant). In one embodiment, a polynucleotide can be introduced that inhibits or decreases degradation of Sdh gene transcripts or gene product. In another embodiment, a polynucleotide can be introduced that encodes an SDH protein that exhibits increased enzymatic activity (for example, via increased resistance to inhibition of enzyme activity). In a further embodiment, a polynucleotide can be introduced that encodes a protein having SDH enzyme activity, wherein the polynucleotide comprises regulatory elements, such as a promoter and/or enhancer sequences, that provide for increased expression of the polynucleotide and/or the protein encoded thereby. In a specific embodiment, the promoter sequence is one that provides for constitutive or tissue-specific (e.g., endosperm) expression. Plants containing the polynucleotide, or progeny thereof, optionally can be screened for increased expression of Sdh gene and/or SDH protein, and/or increased seed or kernel size.
- The subject invention also concerns a mutant sdh plant gene, wherein a plant expressing the mutant gene exhibits decreased levels of gene expression and/or the gene product thereof exhibits decreased levels of SDH enzymatic activity.
- The subject invention also concerns materials and methods for modulating seed number and sugar content in plants. As used herein, sugar content can refer to sugars, e.g., fructose, sucrose, and glucose, and to sugar alcohols, e.g., sorbitol. In one embodiment, seed number and sugar content is increased relative to wild type seed by inhibiting or knocking out expression of a sorbitol dehydrogenase (sdh) gene or the gene product thereof, or a gene linked to the Sdh gene or the expression of the Sdh gene. Any means for inhibiting or knocking out expression of a Sdh gene or gene product, or a gene linked thereto, is contemplated within the scope of the present invention. In one embodiment, Sdh expression can be inhibited using antisense or siRNA technologies. In a further embodiment, a mutant sdh-encoding polynucleotide is introduced into the genome of a target plant. In one embodiment, the mutant sdh-encoding polynucleotide encodes a mutant sorbitol dehydrogenase enzyme with decreased enzymatic activity relative to a non-mutated or wild type SDH enzyme. In a specific embodiment, the mutant sorbitol dehydrogenase enzyme comprises the amino acid sequence shown in SEQ ID NO:1, or a fragment, or variant thereof. In one embodiment, the polynucleotide encoding SEQ ID NO:1 comprises the nucleotide sequence shown in SEQ ID NO:2 or SEQ ID NO:3, or a fragment or variant thereof. In another embodiment, a mutant sdh polynucleotide comprises a mutant nucleotide sequence shown in
FIG. 14B , or a fragment of variant of the sequence. In a further embodiment, a mutant sdh gene is incorporated into the genome of a target plant wherein the mutant sdh gene exhibits decreased or no expression of gene transcripts or translation thereof. In one embodiment, a mutation is introduced into an Sdh gene of a plant that results in decreased transcription of the Sdh gene, or decreased translation of sorbitol dehydrogenase mRNA, and/or that results in a protein exhibiting decreased sorbitol dehydrogenase enzymatic activity. In one embodiment, a mutation is introduced in the Sdh gene upstream of the transcription start site and/or downstream of the transcription start site. In a specific embodiment, a mutation is introduced in the protein coding region of the Sdh gene. Mutations include one or more nucleotide(s) insertions, deletions, or substitutions. Methods for introducing mutations are known in the art. Plants containing a mutant sdh polynucleotide, or progeny thereof, optionally can be screened for expression of a mutant sdh gene or gene product, and/or increased seed number and/or sugar content. - In another embodiment, seed number and sugar content is decreased relative to wild type seed by increasing expression of an Sdh gene or the gene product thereof, or a gene linked to the Sdh gene or the expression of the Sdh gene. In a specific embodiment, an Sdh gene is overexpressed. Overexpression of Sdh can be achieved using any number of means known in the art. For example, a plant can be transformed with multiple copies of a polynucleotide encoding Sdh. In another embodiment, a plant can be transformed with a polynucleotide encoding Sdh, wherein the polynucleotide comprises a promoter and/or other regulatory sequences that provide for increased expression of the polynucleotide, or the Sdh gene product.
- In one embodiment, a method of the invention comprises introducing a polynucleotide into a plant wherein the polynucleotide or the expression product thereof provides for increased expression of Sdh gene or SDH protein relative to a plant wherein the polynucleotide has not been introduced (e.g., a wild type plant). In one embodiment, a polynucleotide can be introduced that inhibits or decreases degradation of Sdh gene transcripts or gene product. In another embodiment, a polynucleotide can be introduced that encodes an SDH protein that exhibits increased enzymatic activity (for example, via increased resistance to inhibition of enzyme activity). In a further embodiment, a polynucleotide can be introduced that encodes a protein having SDH enzyme activity, wherein the polynucleotide comprises regulatory elements, such as a promoter and/or enhancer sequences, that provide for increased expression of the polynucleotide and/or the protein encoded thereby. In a specific embodiment, the promoter sequence is one that provides for constitutive or tissue-specific (e.g., endosperm) expression. Plants containing the polynucleotide, or progeny thereof, optionally can be screened for increased expression of Sdh gene and/or SDH protein, and/or decreased seed or kernel number and/or sugar content.
- In one embodiment, a method of the invention comprises introducing a polynucleotide into a plant wherein the polynucleotide or the expression product thereof provides for decreased expression of Sdh gene or SDH protein relative to a plant wherein the polynucleotide has not been introduced (e.g., a wild type plant). In one embodiment, a polynucleotide can be introduced that increases degradation of Sdh gene transcripts or gene product. In another embodiment, a polynucleotide can be introduced that encodes an SDH protein that exhibits decreased enzymatic activity (for example, via decreased resistance to inhibition of enzyme activity). In a further embodiment, a polynucleotide can be introduced that encodes a protein having SDH enzyme activity, wherein the polynucleotide comprises regulatory elements that provide for decreased expression of the polynucleotide and/or the protein encoded thereby. Plants containing the polynucleotide, or progeny thereof, optionally can be screened for decreased expression of Sdh gene and/or SDH protein, or decreased enzymatic activity of the SDH protein, and/or decreased seed or kernel number.
- In a further embodiment, multiple copies of a polynucleotide encoding a protein with SDH enzymatic activity are introduced into a plant and stably incorporated into the genome of the plant wherein expression of the multiple copies of the polynucleotide results in increased levels of protein having SDH enzymatic activity.
- Embodiments of the invention can preferably provide for expression of a polynucleotide of the invention and any protein encoded thereby in endosperm of a seed or kernel.
- Plants used in the methods of the present invention or resulting from the methods of the invention can also optionally comprise other mutations that impact other phenotypic characteristics, such as seed weight, etc. In one embodiment, a plant, plant tissue, or plant cell of the invention also comprises one or more mutations described in U.S. Pat. Nos. 5,589,618; 5,650,557; 5,872,216; 6,069,300; 6,403,863; 6,809,235; 7,312,378; 6,184,438; 6,969,783; and 7,173,165.
- The subject invention also concerns materials and methods for modulating sorbitol levels in plants, plant tissue, and plant cells. Modulating expression of an Sdh gene can also increase or reduce levels of sorbitol, a sugar alcohol. Changes in sorbitol levels can have diverse effects. One example is its unique influence on embryo-forming endosperm callus, where, unlike other carbon sources, sorbitol supports only embryogenic calli (not non-embryogenic calli) (Swedlund and Locy, 1993). This indicates that sorbitol, or some aspect of its use, is able to affect cell division, differentiation, or meristem formation. Such roles would be consistent with observed changes in the floral meristem of the sdh mutant(s) (where kernel row number on the ear is established). Levels of sorbitol modulated via an sdh mutation can affect the capacity for regeneration of plantlets after transformation, since this is currently a limiting step in the overall process.
- The changes in sorbitol and fructose levels that occur with an sdh mutant provide examples of how altered SDH activity can affect balance of its reactants. As shown in
FIGS. 4A and 4B, these reactants include not only fructose (a sugar), sorbitol (a sugar alcohol), but also the nucleotides, NAD and NADH. Changes to any of these reactants (either their pool sizes or flux to other reactions) can have consequences on diverse processes. Fructose is a known signaling molecule, sorbitol effects indicate a similar possibility, and NAD/NADH balance is also known to affect redox status and signaling. The Sdh gene can be used as a tool to alter the levels, production, or use of these constituents. - The subject invention also concerns plants, plant tissue, and plant cells of the invention that exhibit increased or decreased expression of an Sdh encoding polynucleotide or the protein encoded by the polynucleotide, or that express a mutant sdh polynucleotide or a mutant sdh enzyme of the invention, or a fragment or variant thereof. Plant tissue includes, but is not limited to, seed, scion, and rootstock. In one embodiment, the plant, plant tissue, or plant cell is Zea mays. In one embodiment, a plant, plant tissue, or plant cell is a transgenic plant, plant tissue, or plant cell. In another embodiment, a plant, plant tissue, or plant cell is one that has been obtained through a breeding program. In one embodiment, the plant, plant tissue, or plant cell is homozygous for a mutant sdh polynucleotide or gene. In another embodiment, the plant, plant tissue, or plant cell is heterozygous for a mutant sdh polynucleotide or gene. The mutant sdh polynucleotide or gene can be provided by the maternal parent and/or the paternal parent. In one embodiment, a plant, plant tissue, or plant cell of the invention is a hybrid plant, plant tissue, or plant cell obtained from breeding a plant comprising a polynucleotide that encodes a mutant sdh enzyme of the invention with a plant that comprises a polynucleotide that encodes a wild type SDH enzyme. In one embodiment, a plant of the invention is an inbred line that has been transformed or bred to exhibit increased or decreased expression of an sorbitol dehydrogenase encoding polynucleotide or the protein encoded by the polynucleotide, or that expresses a mutant sdh polynucleotide or a sdh enzyme of the invention. A plant, plant tissue, or plant cell of the invention comprising a polynucleotide that provides for increased or decreased expression of an Sdh encoding polynucleotide or the protein encoded by the polynucleotide, or that comprises a mutant sdh polynucleotide or a mutant sdh enzyme of the invention, can also comprise other mutations that impact other phenotypic characteristics, such as seed weight, etc. In one embodiment, a plant, plant tissue, or plant cell of the invention also comprises one or more mutations described in U.S. Pat. Nos. 5,589,618; 5,650,557; 5,872,216; 6,069,300; 6,403,863; 6,809,235; 7,312,378; 6,184,438; 6,969,783; and 7,173,165.
- The subject invention also concerns an isolated mutant sdh plant gene or polynucleotide, wherein a plant expressing the mutant gene or polynucleotide exhibits decreased levels of SDH enzyme and/or SDH enzymatic activity. In one embodiment, the mutant sdh-encoding polynucleotide encodes an SDH enzyme with decreased enzymatic activity relative to a non-mutated or wild type SDH enzyme. In a specific embodiment, the mutant SDH enzyme comprises the amino acid sequence shown in SEQ ID NO: 1, or a fragment, or variant thereof. In one embodiment, the polynucleotide encoding SEQ ID NO:1 comprises the nucleotide sequence shown in SEQ ID NO:2 or SEQ ID NO:3, or a fragment or variant thereof. In another embodiment, a mutant sdh polynucleotide comprises a mutant nucleotide sequence shown in
FIG. 14B , or a fragment or variant of the sequence. Allelic variants of mutant sdh genes or polynucleotides are included within the scope of the invention. - Polynucleotides useful in the present invention can be provided in an expression construct. Expression constructs of the invention generally include regulatory elements that are functional in the intended host cell in which the expression construct is to be expressed. Thus, a person of ordinary skill in the art can select regulatory elements for use in bacterial host cells, yeast host cells, plant host cells, insect host cells, mammalian host cells, and human host cells. Regulatory elements include promoters, transcription termination sequences, translation termination sequences, enhancers, and polyadenylation elements. As used herein, the term âexpression constructâ refers to a combination of nucleic acid sequences that provides for transcription of an operably linked nucleic acid sequence. As used herein, the term âoperably linkedâ refers to a juxtaposition of the components described wherein the components are in a relationship that permits them to function in their intended manner. In general, operably linked components are in contiguous relation.
- An expression construct of the invention can comprise a promoter sequence operably linked to a polynucleotide sequence encoding a SDH polypeptide of the invention. Promoters can be incorporated into a polynucleotide using standard techniques known in the art. Multiple copies of promoters or multiple promoters can be used in an expression construct of the invention. In a preferred embodiment, a promoter can be positioned about the same distance from the transcription start site in the expression construct as it is from the transcription start site in its natural genetic environment. Some variation in this distance is permitted without substantial decrease in promoter activity. A transcription start site is typically included in the expression construct.
- If the expression construct is to be provided in or introduced into a plant cell, then plant viral promoters, such as, for example, a cauliflower mosaic virus (CaMV) 35S (including the enhanced CaMV 35S promoter (see, for example U.S. Pat. No. 5,106,739)) or a CaMV 19S promoter or a cassava vein mosaic can be used. Other promoters that can be used for expression constructs in plants include, for example, prolifera promoter, Ap3 promoter, heat shock promoters, T-
DNA 1âČ- or 2âČ-promoter of A. tumefaciens, polygalacturonase promoter, chalcone synthase A (CHS-A) promoter from petunia, tobacco PR-1a promoter, ubiquitin promoter, actin promoter, alcA gene promoter, pin2 promoter (Xu et al., 1993), maize Wipl promoter, maize trpA gene promoter (U.S. Pat. No. 5,625,136), maize CDPK gene promoter, and RUBISCO SSU promoter (U.S. Pat. No. 5,034,322) can also be used. Tissue-specific promoters, for example fruit-specific promoters, such as the E8 promoter of tomato (accession number: AF515784; Good et al. (1994)) can be used. Fruit-specific promoters such as flower organ-specific promoters can be used with an expression construct of the present invention for expressing a polynucleotide of the invention in the flower organ of a plant. Examples of flower organ-specific promoters include any of the promoter sequences described in U.S. Pat. Nos. 6,462,185; 5,639,948; and 5,589,610. Seed-specific promoters such as the promoter from a ÎČ-phaseolin gene (for example, of kidney bean) or a glycinin gene (for example, of soybean), and others, can also be used. Endosperm-specific promoters include, but are not limited to, MEG1 (EPO application No. EP1528104) and those described by Wu et al. (1998), Furtado et al. (2001), and Hwang et al. (2002). Root-specific promoters, such as any of the promoter sequences described in U.S. Pat. Nos. 6,455,760 or 6,696,623, or in published U.S. patent application Nos. 20040078841; 20040067506; 20040019934; 20030177536; 20030084486; or 20040123349, can be used with an expression construct of the invention. Constitutive promoters (such as the CaMV, ubiquitin, actin, or NOS promoter), developmentally-regulated promoters, and inducible promoters (such as those promoters than can be induced by heat, light, hormones, or chemicals) are also contemplated for use with polynucleotide expression constructs of the invention. - Expression constructs of the invention may optionally contain a transcription termination sequence, a translation termination sequence, a sequence encoding a signal peptide, and/or enhancer elements. Transcription termination regions can typically be obtained from the 3âČ untranslated region of a eukaryotic or viral gene sequence. Transcription termination sequences can be positioned downstream of a coding sequence to provide for efficient termination. A signal peptide sequence is a short amino acid sequence typically present at the amino terminus of a protein that is responsible for the relocation of an operably linked mature polypeptide to a wide range of post-translational cellular destinations, ranging from a specific organelle compartment to sites of protein action and the extracellular environment. Targeting gene products to an intended cellular and/or extracellular destination through the use of an operably linked signal peptide sequence is contemplated for use with the polypeptides of the invention. Classical enhancers are cis-acting elements that increase gene transcription and can also be included in the expression construct. Classical enhancer elements are known in the art, and include, but are not limited to, the CaMV 35S enhancer element, cytomegalovirus (CMV) early promoter enhancer element, and the SV40 enhancer element. Intron-mediated enhancer elements that enhance gene expression are also known in the art. These elements must be present within the transcribed region and are orientation dependent. Examples include the maize shrunken-1 enhancer element (Clancy and Hannah, 2002).
- DNA sequences which direct polyadenylation of mRNA transcribed from the expression construct can also be included in the expression construct, and include, but are not limited to, an octopine synthase or nopaline synthase signal. The expression constructs of the invention can also include a polynucleotide sequence that directs transposition of other genes, i.e., a transposon.
- Polynucleotides of the present invention can be composed of either RNA or DNA. Preferably, the polynucleotides are composed of DNA. The subject invention also encompasses those polynucleotides that are complementary in sequence to the polynucleotides disclosed herein. Polynucleotides and polypeptides of the invention can be provided in purified or isolated form.
- Because of the degeneracy of the genetic code, a variety of different polynucleotide sequences can encode SDH enzymes useful in the present invention. A table showing all possible triplet codons (and where U also stands for T) and the amino acid encoded by each codon is described in Lewin (1985). In addition, it is well within the skill of a person trained in the art to create alternative polynucleotide sequences encoding the same, or essentially the same, SDH enzymes of the subject invention. These variant or alternative polynucleotide sequences are within the scope of the subject invention. As used herein, references to âessentially the sameâ sequence refers to sequences which encode amino acid substitutions, deletions, additions, or insertions which do not materially alter the functional activity of the polypeptide encoded by the polynucleotides of the present invention. Allelic variants of the nucleotide sequences encoding an SDH or a mutant sdh of the invention are also encompassed within the scope of the invention.
- Substitution of amino acids other than those specifically exemplified or naturally present in an SDH or a mutant sdh enzyme of the invention are also contemplated within the scope of the present invention. For example, non-natural amino acids can be substituted for the amino acids of an SDH or a mutant sdh enzyme, so long as the SDH or a mutant sdh enzyme having the substituted amino acids retains substantially the same functional activity as the SDH or a mutant sdh in which amino acids have not been substituted. Examples of non-natural amino acids include, but are not limited to, ornithine, citrulline, hydroxyproline, homoserine, phenylglycine, taurine, iodotyrosine, 2,4-diaminobutyric acid, α-amino isobutyric acid, 4-aminobutyric acid, 2-amino butyric acid, Îł-amino butyric acid, Δ-amino hexanoic acid, 6-amino hexanoic acid, 2-amino isobutyric acid, 3-amino propionic acid, norleucine, norvaline, sarcosine, homocitrulline, cysteic acid, Ï-butylglycine, Ï-butylalanine, phenylglycine, cyclohexylalanine, ÎČ-alanine, fluoro-amino acids, designer amino acids such as O-methyl amino acids, C-methyl amino acids, N-methyl amino acids, and amino acid analogues in general. Non-natural amino acids also include amino acids having derivatized side groups. Furthermore, any of the amino acids in the protein can be of the D (dextrorotary) form or L (levorotary) form. Allelic variants of a protein sequence of SDH or a mutant sdh enzyme of the present invention are also encompassed within the scope of the invention.
- Amino acids can be generally categorized in the following classes: non-polar, uncharged polar, basic, and acidic. Conservative substitutions whereby an SDH or a mutant sdh enzyme of the present invention having an amino acid of one class is replaced with another amino acid of the same class fall within the scope of the subject invention so long as the SDH or a mutant sdh enzyme having the substitution still retains substantially the same functional activity (e.g., decreased enzymatic activity) as the SDH or a mutant sdh enzyme that does not have the substitution. Polynucleotides encoding an SDH or a mutant sdh enzyme having one or more amino acid substitutions in the sequence are contemplated within the scope of the present invention. Table 1 below provides a listing of examples of amino acids belonging to each class.
-
TABLE 1 Class of Amino Acid Examples of Amino Acids Nonpolar Ala, Val, Leu, Ile, Pro, Met, Phe, Trp Uncharged Polar Gly, Ser, Thr, Cys, Tyr, Asn, Gln Acidic Asp, Glu Basic Lys, Arg, His - The subject invention also concerns variants of the polynucleotides of the present invention that encode enzymatically active SDH enzymes of the invention. Variant sequences include those sequences wherein one or more nucleotides of the sequence have been substituted, deleted, and/or inserted. The nucleotides that can be substituted for natural nucleotides of DNA have a base moiety that can include, but is not limited to, inosine, 5-fluorouracil, 5-bromouracil, hypoxanthine, 1-methylguanine, 5-methylcytosine, and tritylated bases. The sugar moiety of the nucleotide in a sequence can also be modified and includes, but is not limited to, arabinose, xylulose, and hexose. In addition, the adenine, cytosine, guanine, thymine, and uracil bases of the nucleotides can be modified with acetyl, methyl, and/or thio groups. Sequences containing nucleotide substitutions, deletions, and/or insertions can be prepared and tested using standard techniques known in the art.
- Fragments and variants of an SDH or a mutant sdh enzyme of the present invention can be generated as described herein and tested for the presence of enzymatic function using standard techniques known in the art. Thus, an ordinarily skilled artisan can readily prepare and test fragments and variants of an SDH or a mutant sdh enzyme of the invention and determine whether the fragment or variant retains functional enzymatic activity relative to full-length or a non-variant SDH or a mutant sdh enzyme.
- Polynucleotides and polypeptides contemplated within the scope of the subject invention can also be defined in terms of more particular identity and/or similarity ranges with those sequences of the invention specifically exemplified herein. The sequence identity will typically be greater than 60%, preferably greater than 75%, more preferably greater than 80%, even more preferably greater than 90%, and can be greater than 95%. The identity and/or similarity of a sequence can be 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99% as compared to a sequence exemplified herein. Unless otherwise specified, as used herein percent sequence identity and/or similarity of two sequences can be determined using the algorithm of Karlin and Altschul (1990), modified as in Karlin and Altschul (1993). Such an algorithm is incorporated into the NBLAST and)(BLAST programs of Altschul et al. (1990). BLAST searches can be performed with the NBLAST program, score=100, wordlength=12, to obtain sequences with the desired percent sequence identity. To obtain gapped alignments for comparison purposes, Gapped BLAST can be used as described in Altschul et al. (1997). When utilizing BLAST and Gapped BLAST programs, the default parameters of the respective programs (NBLAST and)(BLAST) can be used. See NCBI/NIH website.
- The subject invention also contemplates those polynucleotide molecules having sequences which are sufficiently homologous with the polynucleotide sequences exemplified herein so as to permit hybridization with that sequence under standard stringent conditions and standard methods (Maniatis et al., 1982). As used herein, âstringentâ conditions for hybridization refers to conditions wherein hybridization is typically carried out overnight at 20-25 C. below the melting temperature (Tm) of the DNA hybrid in 6Ă SSPE, 5Ă Denhardt's solution, 0.1% SDS, 0.1 mg/ml denatured DNA. The melting temperature, Tm, is described by the following formula (Beltz et al., 1983):
-
Tm=81.5 C+16.6 Log[Na+]+0.41(%G+C)-0.61(% formamide)-600/length of duplex in base pairs. - Washes are typically carried out as follows:
- (1) Twice at room temperature for 15 minutes in 1Ă SSPE, 0.1% SDS (low stringency wash).
- (2) Once at Tm-20 C for 15 minutes in 0.2Ă SSPE, 0.1% SDS (moderate stringency wash).
- As used herein, the terms ânucleic acidâ and âpolynucleotideâ refer to a deoxyribonucleotide, ribonucleotide, or a mixed deoxyribonucleotide and ribonucleotide polymer in either single- or double-stranded form, and unless otherwise limited, would encompass known analogs of natural nucleotides that can function in a similar manner as naturally-occurring nucleotides. The polynucleotide sequences include the DNA strand sequence that is transcribed into RNA and the strand sequence that is complementary to the DNA strand that is transcribed. The polynucleotide sequences also include both full-length sequences as well as shorter sequences derived from the full-length sequences. Allelic variations of polynucleotide sequences of the invention also fall within the scope of the subject invention. The polynucleotide sequence includes both the sense and antisense strands either as individual strands or in the duplex.
- Plants within the scope of the present invention include monocotyledonous plants, such as, for example, rice, wheat, barley, oats, rye, sorghum, maize, sugarcane, pineapple, onion, bananas, coconut, lilies, turfgrasses, and millet. Plants within the scope of the present invention also include dicotyledonous plants, such as, for example, tomato, cucumber, squash, peas, alfalfa, melon, chickpea, chicory, clover, kale, lentil, soybean, beans, tobacco, potato, sweet potato, yams, cassava, radish, broccoli, spinach, cabbage, rape, apple trees, citrus (including oranges, mandarins, grapefruit, lemons, limes and the like), grape, cotton, sunflower, strawberry, and lettuce. Herb plants containing a polynucleotide of the invention are also contemplated within the scope of the invention. Herb plants include parsley, sage, rosemary, thyme, and the like.
- Techniques for transforming plant cells with a gene are known in the art and include, for example, Agrobacterium infection, biolistic methods, electroporation, calcium chloride treatment, PEG-mediated transformation, etc. U.S. Pat. No. 5,661,017 teaches methods and materials for transforming an algal cell with a heterologous polynucleotide. Transformed cells can be selected, redifferentiated, and grown into plants that contain and express a polynucleotide of the invention using standard methods known in the art. The seeds and other plant tissue and progeny of any transformed or transgenic plant cells or plants of the invention are also included within the scope of the present invention.
- The subject invention also concerns methods for producing a plant that exhibits increased or decreased SDH content and/or enzymatic activity relative to a wild type plant, wherein a polynucleotide encoding an SDH or a mutant sdh enzyme of the present invention is introduced into a plant cell and the polypeptide(s) encoded by the polynucleotide(s) is expressed. In one embodiment, the polynucleotide or polynucleotides is incorporated into the genome of the plant cell and a plant is grown from the plant cell. In a preferred embodiment, the plant grown from the plant cell stably expresses the incorporated polynucleotide or polynucleotides.
- The subject invention also concerns methods and materials for selecting for plants having increased or decreased seed size, seed number and/or sugar content. In one embodiment, a mutant sdh gene or polynucleotide that encodes an SDH enzyme having decreased enzymatic activity relative to a wild type or non-mutated SDH is utilized as a genetic marker. In a specific embodiment, the SDH enzyme comprises an amino acid sequence of SEQ ID NO: 1, or a fragment or variant thereof. In a specific embodiment, the mutant sdh gene or polynucleotide comprises a nucleotide sequence of SEQ ID NO: 2 or SEQ ID NO: 3, or a mutant sequence shown in
FIG. 14B , or a fragment or variant thereof. Methods of the invention comprise determining whether a plant, plant tissue, or plant cell contains a mutant sdh gene or polynucleotide of the invention, and/or determining whether a plant, plant tissue, or plant cell comprises or expresses a mutant SDH enzyme of the present invention. In one embodiment, the presence of a mutant sdh gene or polynucleotide is determined by screening nucleic acid from the plant, plant tissue, or plant cell for hybridization with a nucleic acid probe (e.g., an oligonucleotide of the invention) that hybridizes with a mutant sdh gene or polynucleotide of the invention. In another embodiment, the presence of a mutant sdh gene or polynucleotide is determined by restriction fragment length polymorphism (RFLP) analysis, by polymerase chain reaction (PCR) amplification of specific sdh nucleic acid sequences, or by sequencing sdh-encoding nucleic acid from the plant, plant tissue, or plant cell and identifying whether the gene or polynucleotide comprises a mutant sequence that provides for decreased sdh mRNA levels or decreased SDH enzymatic activity. - The subject invention also concerns methods for marker assisted selection and breeding in plants using a gene or polynucleotide that provides for modulated expression (increased or decreased) of Sdh or the gene product thereof for selecting for plants, plant tissue, or plant cells that exhibit a phenotypic characteristic of interest, e.g., increased or decreased seed size, seed number, sugar content, etc. Methods for marker assisted selection are known in the art. In one embodiment, a method uses a mutant sdh gene or polynucleotide of the invention that encodes a sorbitol dehydrogenase enzyme that is non-functional or that exhibits decreased enzymatic activity relative to a non-mutant SDH enzyme, or wherein the mutant sdh gene or polynucleotide provides for decreased or no expression of gene transcripts or translation of gene transcripts.
- The subject invention also concerns oligonucleotide probes and primers, such as polymerase chain reaction (PCR) primers, that can hybridize to a coding or non-coding sequence of a polynucleotide of the present invention. Oligonucleotide probes of the invention can be used in methods for detecting and quantitating nucleic acid sequences encoding a sorbitol dehydrogenase. Oligonucleotide primers of the invention can be used in PCR methods and other methods involving nucleic acid amplification. In a preferred embodiment, a probe or primer of the invention can hybridize to a polynucleotide of the invention under stringent conditions. Probes and primers of the invention can optionally comprise a detectable label or reporter molecule, such as fluorescent molecules, enzymes, radioactive moiety (e.g., 3H, 35S, 125I, etc.), and the like. Probes and primers of the invention can be of any suitable length for the method or assay in which they are being employed. Typically, probes and primers of the invention will be 10 to 500 or more nucleotides in length. Probes and primers that are 10 to 20, 21 to 30, 31 to 40, 41 to 50, 51 to 60, 61 to 70, 71 to 80, 81 to 90, 91 to 100 or more nucleotides in length are contemplated within the scope of the invention. Probes and primers of the invention can have complete (100%) nucleotide sequence identity with the polynucleotide sequence, or the sequence identity can be less than 100%. For example, sequence identity between a probe or primer and a sequence can be 99%, 98%, 97%, 96%, 95%, 90%, 85%, 80%, 75%, 70% or any other percentage sequence identity so long as the probe or primer can hybridize under stringent conditions to a nucleotide sequence of a polynucleotide of the invention. In one embodiment, a probe or primer of the invention has 70% or greater, 75% or greater, 80% or greater, 85% or greater, 90% or greater, or 95% to 100% sequence identity with a nucleotide sequence of SEQ ID NO: 2 or SEQ ID NO: 3, or the complement thereof.
- The subject invention also concerns an isolated mutant sorbitol dehydrogenase. In one embodiment, the mutant sorbitol dehydrogenase is a
sorbitol dehydrogenase 1 of Zea mays. In a specific embodiment, a sorbitol dehydrogenase enzyme of the invention has an amino acid sequence as shown in SEQ ID NO: 1, or an enzymatically active fragment or variant thereof. A sorbitol dehydrogenase enzyme of the invention can be purified using standard techniques known in the art. In one embodiment, a polynucleotide of the invention encoding a sorbitol dehydrogenase is incorporated into a microorganism, such as E. coli, and the sorbitol dehydrogenase expressed in the microorganism and then its protein product isolated therefrom. - Polypeptides of the invention, and peptide fragments thereof, can be used to generate antibodies that bind specifically to a polypeptide of the invention, and such antibodies are contemplated within the scope of the invention. The antibodies of the invention can be polyclonal or monoclonal and can be produced and isolated using standard methods known in the art.
- Polypeptide fragments according to the subject invention typically comprise a contiguous span of about or at least 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362, 363, 364, or 365 amino acids of SEQ ID NO: 1.
- Polypeptide fragments of the subject invention can be any integer in length from at least about 25 consecutive amino acids to 1 amino acid less than the sequence shown in SEQ ID NO: 1. Thus, for SEQ ID NO: 1, a polypeptide fragment can be any integer of consecutive amino acids from about 25 to 365 amino acids. The term âintegerâ is used herein in its mathematical sense and thus representative integers include: 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362, 363, 364, and/or 365.
- Each polypeptide fragment of the subject invention can also be described in terms of its N-terminal and C-terminal positions. For example, combinations of N-terminal to C-terminal fragments of about 25 contiguous amino acids to 1 amino acid less than the full length polypeptide of SEQ ID NO: 1 are included in the present invention. Thus, using SEQ ID NO: 1 as an example, a 25 consecutive amino acid fragment could correspond to amino acids of SEQ ID NO: 1 selected from the group consisting of 1-25, 2-26, 3-27, 4-28, 5-29, 6-30, 7-31, 8-32, 9-33, 10-34, 11-35, 12-36, 13-37, 14-38, 15-39, 16-40, 17-41, 18-42, 19-43, 20-44, 21-45, 22-46, 23-47, 24-48, 25-49, 26-50, 27-51, 28-52, 29-53, 30-54, 31-55, 32-56, 33-57, 34-58, 35-59, 36-60, 37-61, 38-62, 39-63, 40-64, 41-65, 42-66, 43-67, 44-68, 45-69, 46-70, 47-71, 48-72, 49-73, 50-74, 51-75, 52-76, 53-77, 54-78, 55-79, 56-80, 57-81, 58-82, 59-83, 60-84, 61-85, 62-86, 63-87, 64-88, 65-89, 66-90, 67-91, 68-92, 69-93, 70-94, 71-95, 72-96, 73-97, 74-98, 75-99, 76-100, 77-101, 78-102, 79-103, 80-104, 81-105, 82-106, 83-107, 84-108, 85-109, 86-110, 87-111, 88,-112, 89-113, 90-114, 91-115, 92-116, 93-117, 94-118, 95-119, 96-120, 97-121, 98-122, 99-123, 100-124, 101-125, 102-126, 103-127, 104-128, 105-129, 106-130, 107-131, 108-132, 109-133, 110-134, 111-135, 112-136, 113-137, 114-138, 115-139, 116-140, 117-141, 118-142, 119-143, 120-144, 121-145, 122-146, 123-147, 124-148, 125-149, 126-150, 127-151, 128-152, 129-153, 130-154, 131-155, 132-156, 133-157, 134-158, 135-159, 136-160, 137-161, 138-162, 139-163, 140-164, 141-165, 142-166, 143-167, 144-168, 145-169, 146-170, 147-171, 148-172, 149-173, 150-174, 151-175, 152-176, 153-177, 154-178, 155-179, 156-180, 157-181, 158-182, 159-183, 160-184, 161-185, 162-186, 163-187, 164-188, 165-189, 166-190, 167-191, 168-192, 169-193, 170-194, 171-195, 172-196, 173-197, 174-198, 175-199, 176-200, 177-201, 178-202, 179-203, 180-204, 181-205, 182-206, 183-207, 184-208, 185-209, 186-210, 187-211, 188-212, 189-213, 190-214, 191-215, 192-216, 193-217, 194-218, 195-219, 196-220, 197-221, 198-222, 199-223, 200-224, 201-225, 202-226, 203-227, 204-228, 205-229, 206-230, 207-231, 208-232, 209-233, 210-234, 211-235, 212-236, 213-237, 214-238, 215-239, 216-240, 217-241, 218-242, 219-243, 220-244, 221-245, 222-246, 223-247, 224-248, 225-249, 226-250, 227-251, 228-252, 229-253, 230-254, 231-255, 232-256, 233-257, 234-258, 235-259, 236-260, 237-261, 238-262, 239-263, 240-264, 241-265, 242-266, 243-267, 244-268, 245-269, 246-270, 247-271, 248-272, 249-273, 250-274, 251-275, 252-276, 253-277, 254-278, 255-279, 256-280, 257-281, 258-282, 259-283, 260-284, 261-285, 262-286, 263-287, 264-288, 265-289, 266-290, 267-291, 268-292, 269-293, 270-294, 271-295, 272-296, 273-297, 274-298, 275-299, 276-300, 277-301, 278-302, 279-303, 280-304, 281-305, 282-306, 283-307, 284-308, 285-309, 286-310, 287-311, 288-312, 289-313, 290-314, 291-315, 292-316, 293-317, 294-318, 295-319, 296-320, 297-321, 298-322, 299-323, 300-324, 301-325, 302-326, 303-327, 304-328, 305-329, 306-330, 307-331, 308-332, 309-333, 310-334, 311-335, 312-336, 313-337, 314-338, 315-339, 316-340, 317-341, 318-342, 319-343, 320-344, 321-345, 322-346, 323-347, 324-348, 325-349, 326-350, 327-351, 328-352, 329-353, 330-354, 331-355, 332-356, 333-357, 334-358, 335-359, 336-360, 337-361, 338-362, 339-363, 340-364, 341-365, 342-366. Similarly, the amino acids corresponding to all other fragments of sizes between 26 consecutive amino acids and 365 consecutive amino acids of SEQ ID NO: 1 are included in the present invention and can also be immediately envisaged based on these examples. Therefore, additional examples, illustrating various fragments of the polypeptides of SEQ ID NO: 1 are not individually listed herein in order to avoid unnecessarily lengthening the specification.
- Polypeptide fragments comprising: 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362, 363, 364, and 365 consecutive amino acids of SEQ ID NO: 1 may alternatively be described by the formula ân to câ (inclusive), where ânâ equals the N-terminal amino acid position and âcâ equals the C-terminal amino acid position of the polypeptide. In this embodiment of the invention, ânâ is an integer having a lower limit of 1 and an upper limit of the total number of amino acids of the full length polypeptide minus 24 (e.g., 366-24=342 for SEQ ID NO: 1). âcâ is an integer between 25 and the number of amino acids of the full length polypeptide sequence (366 for SEQ ID NO: 1) and ânâ is an integer smaller than âcâ by at least 24. Therefore, for SEQ ID NO: 1, ânâ is any integer selected from the list consisting of: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, and 342; and âcâ is any integer selected from the group consisting of: 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 351, 352, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, and 366 provided that ânâ is a value less than âcâ by at least 24. Every combination of ânâ and âcâ positions are included as specific embodiments of polypeptide fragments of the invention. All ranges used to describe any polypeptide fragment embodiment of the present invention are inclusive unless specifically set forth otherwise.
- Fragments of a sorbitol dehydrogenase of the invention, as described herein, can be obtained by cleaving the polypeptides of the invention with a proteolytic enzyme (such as trypsin, chymotrypsin, or collagenase) or with a chemical reagent, such as cyanogen bromide (CNBr). Alternatively, polypeptide fragments can be generated in a highly acidic environment, for example at pH 2.5. Polypeptide fragments can also be prepared by chemical synthesis or using host cells transformed with an expression vector comprising a polynucleotide encoding a fragment of a sorbitol dehydrogenase enzyme of the invention, for example, a sorbitol dehydrogenase that is a fragment of the amino acid sequence shown in SEQ ID NO: 1.
- The subject invention also concerns cells transformed with a polynucleotide of the present invention encoding a sorbitol dehydrogenase of the invention. In one embodiment, the cell is transformed with a polynucleotide sequence comprising a sequence encoding the amino acid sequence shown in SEQ ID NO: 1, or an enzymatically active fragment or variant thereof. In a specific embodiment, the cell is transformed with a polynucleotide sequence shown in SEQ ID NO: 2 or 3, or a sequence encoding an enzymatically active fragment or variant of SEQ ID NO:1. In another embodiment, a mutant sdh polynucleotide comprises a mutant nucleotide sequence shown in
FIG. 14B , or a fragment or variant of the nucleotide sequence. - Preferably, the polynucleotide sequence is provided in an expression construct of the invention. The transformed cell can be a prokaryotic cell, for example, a bacterial cell such as E. coli or B. subtilis, or the transformed cell can be a eukaryotic cell, for example, a plant cell, including protoplasts, or an animal cell. Plant cells include, but are not limited to, dicotyledonous, monocotyledonous, and conifer cells. In one embodiment, the plant cell is a cell from a Zea mays plant. Animal cells include human cells, mammalian cells, avian cells, and insect cells. Mammalian cells include, but are not limited to, COS, 3T3, and CHO cells.
- An âantisenseâ nucleic acid sequence (antisense oligonucleotide) can include a nucleotide sequence that is complementary to a âsenseâ nucleic acid sequence encoding a protein, e.g., complementary to the coding strand of a double-stranded cDNA molecule or complementary to at least a portion of an Sdh gene. The antisense nucleic acid sequence can be complementary to an entire coding strand of a target sequence, or to only a portion thereof. In another embodiment, the antisense nucleic acid molecule is antisense to a ânoncoding regionâ of the coding strand of a nucleotide sequence within the gene. An antisense oligonucleotide can be, for example, about 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, or more nucleotides in length.
- An antisense nucleic acid sequence can be designed such that it is complementary to the entire gene, but can also be an oligonucleotide that is antisense to only a portion of the gene. For example, the antisense oligonucleotide can be complementary to the region surrounding the translation start site of the target mRNA, e.g., between the â10 and +10 regions of the target gene nucleotide sequence of interest.
- An antisense nucleic acid sequence of the invention can be constructed using chemical synthesis and enzymatic ligation reactions using procedures known in the art. For example, an antisense nucleic acid (e.g., an antisense oligonucleotide) can be chemically synthesized using naturally occurring nucleotides or variously modified nucleotides designed to increase the biological stability of the molecules or to increase the physical stability of the duplex formed between the antisense and sense nucleic acids, e.g., phosphorothioate derivatives and acridine substituted nucleotides can be used. The antisense nucleic acid sequence also can be produced biologically using an expression vector into which a nucleic acid sequence has been subcloned in an antisense orientation (i.e., RNA transcribed from the inserted nucleic acid sequence will be of an antisense orientation to a target nucleic acid sequence of interest, described further in the following sub section).
- Ribozymes are a type of RNA that can be engineered to enzymatically cleave and inactivate other RNA targets in a specific, sequence-dependent fashion. By cleaving the target RNA, ribozymes inhibit translation, thus preventing the expression of the target gene. Ribozymes can be chemically synthesized in the laboratory and structurally modified to increase their stability and catalytic activity using methods known in the art. Alternatively, ribozyme encoding nucleotide sequences can be introduced into cells through gene-delivery mechanisms known in the art. A ribozyme having specificity for Sdh RNA can include one or more sequences complementary to the nucleotide sequence of at least a portion of one or more Sdh mRNA, and a sequence having known catalytic sequence responsible for mRNA cleavage (see U.S. Pat. No. 5,093,246 or Haselhoff et al. 1988). For example, a derivative of a Tetrahymena L-19 IVS RNA can be constructed in which the nucleotide sequence of the active site is complementary to the nucleotide sequence to be cleaved in the Sdh mRNA (see, e.g., U.S. Pat. Nos. 4,987,071; and 5,116,742). Alternatively, Sdh mRNA encoding an Sdh protein can be used to select a catalytic RNA having a specific ribonuclease activity from a pool of RNA molecules (see, e.g., Bartel et al. 1993).
- As used herein, the term âRNA interferenceâ (âRNAiâ) refers to a selective intracellular degradation of RNA. RNAi occurs in cells naturally to remove foreign RNAs (e.g., viral RNAs). Natural RNAi proceeds via fragments cleaved from free dsRNA which direct the degradative mechanism to other similar RNA sequences. Alternatively, RNAi can be initiated by the hand of man, for example, to silence the expression of target genes.
- As used herein, the term âshort interfering RNAâ (âsiRNAâ) refers to an RNA (or RNA analog) comprising between about 10-50 nucleotides (or nucleotide analogs) which is capable of directing or mediating RNA interference.
- As used herein, a siRNA having a âsequence sufficiently complementary to a target mRNA sequence to direct target-specific RNA interference (RNAi)â means that the siRNA has a sequence sufficient to trigger the destruction of the target mRNA by the RNAi machinery or process. âmRNAâ, âmessenger RNAâ, and âtranscriptâ each refer to single-stranded RNA that specifies the amino acid sequence of one or more polypeptides. This information is translated during protein synthesis when ribosomes bind to the mRNA.
- Single letter amino acid abbreviations are defined in Table 4.
-
TABLE 4 Letter Symbol Amino Acid A Alanine B Asparagine or aspartic acid C Cysteine D Aspartic Acid E Glutamic Acid F Phenylalanine G Glycine H Histidine I Isoleucine K Lysine L Leucine M Methionine N Asparagine P Proline Q Glutamine R Arginine S Serine T Threonine V Valine W Tryptophan Y Tyrosine Z Glutamine or glutamic acid - All patents, patent applications, provisional applications, and publications referred to or cited herein are incorporated by reference in their entirety, including all figures and tables, to the extent they are not inconsistent with the explicit teachings of this specification.
- Following are examples which illustrate procedures for practicing the invention. These examples should not be construed as limiting. All percentages are by weight and all solvent mixture proportions are by volume unless otherwise noted.
- High levels of expression in kernels initially drew attention to the maize Sorbitol dehydrogenase-1 gene (Sdh1). The Sdh1 transcripts were among the most abundant of any ESTs in libraries of maize kernels at 10 days after pollination (DAP) (MAIZEST database).
- Initial work (
FIG. 2 ) showed high levels of expression for the Sdh1 gene and abundant activity of the SDH enzyme in endosperm of maize kernels at 10 DAP (days after pollination). In addition, Sdh1 expression was essentially endosperm-specific relative to other tissues examined. Further analysis indicated gradients of in situ SDH activity within the endosperm (FIG. 3 ), but little to no activity was evident for embryo tissue. This was perplexing given previous reports of abundant sorbitol in these structures (Carey et al., 1982; Doehlert et al., 1988), but subsequent data from de Sousa (see below) confirmed that there was minimal SDH activity or Sdh1 mRNA in embryos. - The possibility thus arose that sorbitol might move from endosperm to embryo (as diagramed in
FIG. 4A ), and there be metabolized by an as-yet-undefined means (low levels of SDH or a distinctive maize aldose reductase (AR)). Additional data also indicated that the reversible reaction of SDH could contribute to metabolic cycling with the potential to aid balance of key reactants and/or shuttle them from one site to another (As drawn inFIG. 4B ). This possibility would include control of pool sizes for signaling molecules (like fructose) or redox control (as for NAD/NADH), and could operate in tissues other than seeds (e.g. floral apecies). To test the first portion of this scenario (sorbitol transfer and use in kernels), embryos were examined for their capacity to take-up and metabolize exogenous sorbtiol (FIG. 5 ). Sorbitol proved to be an excellent C-source for developing maize embryos, supporting their growth and germination as well as did sucrose, glucose, or fructose. Mannitol did not. Additional data from de Sousa (not shown) demonstrated that 13C-sorbitol micro-injected into the endosperm crown of intact, attached kernels, could move into developing embryos. Co-injection of water-soluble dye (aniline) did not follow the same path, indicating that simple diffusion could not account for the sorbitol transfer. Developing maize embryos can thus serve as effective sinks for sorbitol produced within the kernel. - Further analysis of the Sdh1 gene and its regulation showed that it was sugar-responsive (
FIG. 6A ), and that it is up-regulation by sucrose was significant at the level of SDH enzyme activity (FIG. 6B ). Expression of the Sdh1 gene was also enhanced in the high-sugar environment of developing shrunken2 mutant âsweet cornâ (FIG. 7 ). - An sdh1 mutant was isolated from the Uniform-Mu maize population by screening the Reverse-Genetics Grids with gene-specific probes and primers. The Mu insertion was at the far 5âČ end of the sdh1 gene, immediately upstream of the start site (
FIG. 8 ). - There are several important advantages to having obtained this mutant from the UniformMu population. The first of these is the uniform background, which is invaluable for comparisons to wildtype controls. The high degree of genetic similarity results from 9 generations of back-crossing to the W22 inbred (McCarty et al., 2005). The second advantage is the low mutant-load from previous generations, due to continual removal of any mutations, and repeated back-crossing to the inbred. The sdh1 mutant has been backcrossed 2 additional times. This maximizes the probability of a causal linkage between the observed phenotype and the sdh1 mutation. A third advantage is a capacity to fully-stabilize new mutants by selecting those lacking a functional transposase gene (using a color marker), and this has been completed for the sdh1 mutant.
-
FIG. 9 shows both the reduced size of sdh1 kernels and their deficiency in SDH activity (the latter by in situ activity stain and quantified assays). Maximal activity of SDH from mutant kernels remained less than 6% of that from wildtype. Dried-seed weight of sdh1 kernels was 21% less than that of wildtype (p<0.001 from first-year greenhouse and field studies) (FIG. 10 ). No differences were detectable between wildtype and heterozygous kernels although levels of Sdh1 mRNA were approximately 30% less (not shown). Similar results were observed when kernel size was compared on sdh1 and wildtype ears selected for similar overall kernel numbers. - Data indicate that the number of maize kernels per ear can be increased by 2- to 3-fold using a dysfunctional gene for Sdh1 (Sorbitol dehydrogenase 1). Analyses show that sdh mutants lacking a functional Sdh1 gene typically produced at least twice as many kernels per ear (
FIG. 11 ). Kernel number also rose even if the dysfunctional sdh mutant gene was contributed by only one parent (sdh males increased kernel number by 2-fold, and sdh females by 3-fold) (FIG. 12A ). These instances were notable in not necessarily reducing kernel size as was typical when both parents were sdh1 mutants. Combined effects of kernel size and kernel number were reflected in total ear weight (FIG. 12B ), which was significantly increased when a single parent carried the mutant sdh gene. Mutant sdh males raised total ear weight by 30%, and sdh females enhanced ear weight by 85%. Similar increases were not evident when both parents were sdh mutants. A dysfunctional sdh1 gene can thus contribute to yield potential by increasing kernel number, especially when used in combination with a non-mutant parent. (Campos et al. [Pioneer Hi-Bred Intl] found that kernel number per ear, especially the second ear on the plant, was one of the greatest single plant components contributing to maize yields in the United States [unpublished data]). - The prominent effect of an sdh mutant gene from the maternal parent was further examined by comparing ears of all wildtype females to those of all sdh mutant females, regardless of the pollen parent utilized (wt or sdh) (
FIG. 13 ). Results showed that contrasts between key features of wildtype and mutant ears were evident to the same degree for all wildtype and mutant mothers, even when male parents differed. Clear maternal influence was indicated for the number of kernels per ear (FIG. 13A , plus data above), kernels per row (FIG. 13B ), and rows per ear (FIG. 13C ). Despite the greater number of kernels per ear, the ear length was significantly reduced for sdh mutants receiving their own pollen (FIG. 13D ). This extent of decrease in ear length was not evident for all sdh mothers, but cobs born on these females did have consistently shorter zones without developing kernels at their ear-tips (0.8 vs 2.2 cm, data not shown). - A particularly interesting contribution by the sdh mutation to kernel number is its effect on numbers of rows per ear, which increased an average of 25% for sdh mutant females (
FIG. 13C ). This was unexpected because row number is determined early in floral development, much before pollination, and prior to previously-detected expression of the Sdh1 gene (de Sousa et al., in preparation). Since the sdh mutation alters floral architecture more than 12 days before pollination, it must do so in minute primordial tissues of the newly-forming flower, where changes in gene expression could initially have been missed. The site and timing of this effect is also unexpected for a metabolic enzyme, but examples are emerging in maize and other systems for often-surprising contributions by sugar metabolism to changes in development. Examples include the influence of trehalose phosphate on floral architecture and other developmental features (Grennan, 2007), contributions by sugar pulses to induction of flowering in the apical meristem (Bernier and Perilleux), and complex effects of sugar metabolism on expression of genes for growth and development (Koch, 1996; Ohto et al., 2001; and Koch, 2004). - In addition, data presented here (
FIGS. 14 and 15 ) indicate a link between effects of a dysfunctional sdh1 gene and its role in hybrid vigor of maize. We have determined that the âwildtypeâ sdh1 gene in the widely-used B73 inbred (and source of the reference maize genome sequence as of 2008) is actually a naturally-occurring sdh1 mutant If this sdh1 has limited function (as predicted by the site of its insert (see below) and data not shown), then this mutation may contribute significantly to the âcombining abilityâ of B73 for hybrid corn production by increasing the number of kernels available for filling. -
FIG. 14A shows the site of transposon inserts in the different sdh1 mutant genes.FIG. 14B compares the sequence of the B73 sdh1 mutant gene to that of a wildtype Sdh1 gene from a W22 inbred. The insert into the B73 gene is about 100kb long and has characteristic features of a small transposable element (terminal inverted repeats at each end of the inserted sequence). The âwildtypeâ Sdh1 sequence available from GenBank is the mutated B73 sdh allele shown inFIG. 14B . Its mutant status was not evident until it was compared to a true wildtype gene lacking the transposable element disruption to its sequence. The original B73 sequence was submitted to GenBank by Sylvia de Sousa with a date for public release of Jul. 30, 2006. The GenBank accession number for this nucleotide sequence of sorbitol dehydrogenase is: bankit734791 DQ191049. - Further evidence for dysfunction of a mutant sdh1 gene is shown in
FIG. 15 .Sorbitol dehydrogenase 1 gene expression is reduced to barely detectable mRNA levels throughout development of kernels from the B73 inbred, but not for those of the W22 inbred with its intact Sdh1 sequence. The B73 inbred has long been known for phenotypic features that resemble those conferred by the sdh1 mutant gene. These include a large number of somewhat smaller seeds, and a shorter, wider ear. These characters also appear to have contributed to the strength of B73 as a combinatorial partner in hybrid maize. -
FIG. 16 shows higher levels of sucrose, glucose, and fructose in sdh1-mutant kernels when these are compared to wildtype kernels at stages of development when sweet corn is typically harvested. Differences are not evident at kernel maturity, but persist during the sweet-corn harvest period (about 20 to 25 days after pollination (DAP)). Glucose and fructose, in particular, are about 2-fold greater in sdh1-than in wildtype kernels at 25 days after pollination (DAP). The possible usefulness of altered sdh1 expression in sweet corn lines is compatible with the observed up-regulation of this gene by sugars (noted earlier inFIGS. 6A and 6B ) and in other, currently used sweet-corn lines (shown earlier for the shrunken2, sweet-corn mutant inFIG. 7 ). -
FIG. 17 shows that the sdh1 mutant kernels have reduced starch levels at maturity (about 25% less). Starch reductions are typical of sweet-corn mutations, but the level of starch remaining here (and available for seed germination) is considerably greater than for most sweet corn lines. Protein content and zein composition of sdh1 kernels remained similar to those of wildtype kernels. - It should be understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application. In addition, any elements or limitations of any invention or embodiment thereof disclosed herein can be combined with any and/or all other elements or limitations (individually or in any combination) or any other invention or embodiment thereof disclosed herein, and all such combinations are contemplated with the scope of the invention without limitation thereto.
-
- U.S. Pat. No. 6,642,435
- U.S. Pat. No. 5,512,466
- U.S. Pat. No. 5,625,136
- U.S. Pat. No. 5,034,322
- U.S. Pat. No. 5,589,610
- U.S. Pat. No. 5,639,948
- U.S. Pat. No. 6,462,185
- U.S. Pat. No. 5,106,739
- U.S. Pat. No. 6,455,760
- U.S. Pat. No. 6,696,623
- U.S. Pat. No. 5,661,017
- U.S. Pat. No. 5,093,246
- U.S. Pat. No. 5,116,742
- U.S. Pat. No. 4,987,071
- U.S. Pat. No. 5,589,618
- U.S. Pat. No. 5,650,557
- U.S. Pat. No. 5,872,216
- U.S. Pat. No. 6,069,300
- U.S. Pat. No. 6,403,863
- U.S. Pat. No. 6,809,235
- U.S. Pat. No. 7,312,378
- U.S. Pat. No. 6,184,438
- U.S. Pat. No. 6,969,783
- U.S. Pat. No. 7,173,165
- U.S. Published Application No. 20040078841
- U.S. Published Application No. 20040067506
- U.S. Published Application No. 20040019934
- U.S. Published Application No. 20030177536
- U.S. Published Application No. 20030084486
- U.S. Published Application No. 20040123349
- EPO Patent Published Application No. EP1528104
- Altschul, S. F. et al. (1990) âBasic Local Alignment Search Toolâ J. Mol. Biol. 215:402-410.
- Altschul, S. F. et al. (1997) âGapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programsâ Nucl. Acids Res. 25:3389-3402.
- An, G. (1987) In: Methods in Enzymology, 153, eds. Wu, R. and Grossman, L. (Academic Press, New York), pp. 292-305.
- Archbold, D. D. (1999). Carbohydrate availability modifies sorbitol dehydrogenase activity of apple fruit. Physiologia Plantarum 105:391-395.
- Bagley, P. J. & Selhub, J. (2000) âAnalysis of folate form distribution by affinity followed by reversed-phase chromatography with electrical detectionâ Clin. Chem. 46(3):404-111.
- Bartel, D. and Szostak, J. W. Science 261:1411-1418 (1993)
- Basset, G. J., Quinlivan, E. P., Ravanel, S., RĂ©beillĂ©, F., Nichols, B. P., Shinozaki, K., Seki, M., Adams-Phillips, L. C., Giovannoni, J. J, Gregory, J. F. III, Hanson A. D. (2004) âFolate synthesis in plants: the p-aminobenzoate branch is initiated by a bifunctional PabA-PabB protein that is targeted to plastidsâ Proc. Natl. Acad. Sci. USA 101(6):1496-1501.
- Basset, G., Quinlivan, E. P., Ziemak, M.J., Diaz de la Garza, R., Fischer, M., Schiffmann, S., Bacher, A., Gregory, J. F. III & Hanson, A. D. (2002) âFolate synthesis in plants: the first step of the pterin branch is mediated by a unique bimodular GTP cyclohydrolase Iâ Proc. Natl. Acad. Sci. USA 99(19):12489-12494.
- Bechtold, N., Ellis, J. & Pelletier, G. (1993) C. R. Acad. Sci. Paris Life Sci. 316:1194-1199.
- Beltz, G. A., Jacobs, K. A., Eickbush, T. H., Cherbas, P. T., Kafatos, F. C. (1983) âIsolation of multigene families and determination of homologies by filter hybridization methodsâ Methods of Enzymology, R. Wu, L. Grossman and K. Moldave [eds.] Academic Press, New York 100:266-285.
- Bergmeyer, H. U. (1987). Methods of Enzymatic Analysis. VCH, Weinheim, Germany.
- Bernier, G, and C Perilleaux (2005) A physiological overview of the genetics of flowering time control.
Plant Biotechnol 1 3: 3-16. - Bieleski, R. L. (1982). Sugar alcohols. In Encyclopedia of Plant Physiology, New Series vol 13. Edited by Loewus, F. and Tanner, W. 158-192. Springer-Verlag, Berlin.
- Bieleski, R. L., Redgwell. (1985). Sorbitol versus sucrose as photosynthesis and translocation products in developing apricot leaves. Aust. J. Plant. Physiol. 12:657-668.
- Blakley, R. L. (1951). The metabolism and antiketogenic effects of sorbitol. Sorbitol dehydrogenase. Biochem. J. 49:257-271.
- Blattner, F. R., Plunkett, G. III, Bloch, C. A., Perna, N. T., Burland, V., Riley, M., Collado-Vides, J., Glasner, J. D., Rode, C. K., Mayhew, G. F. et al. (1997) Science 277:1453-1474.
- Boggio, S. B., Palatnik, J. F., Heldt, H. W. & Valle, E. M. (2000) âChanges in amino acid composition and nitrogen metabolizing enzymes in ripening fruits of Lycopersicon esculentum Millâ Plant Sci. 159(1):125-133.
- Bouis, H. E. (2002) âPlant breeding: a new tool for fighting micronutrient malnutritionâ J. Nutr. 132(3):4915-4945.
- Bradford, M. M. (1976) Anal. Biochem. 72:248-254.
- Bruce, W. B., Quail, P. H. (1990). cis-Acting elements involved on photoregulation of an oat phytochrome promoter in rice. Plant Cell 2:1081-1089.
- Callis, J., Fromm, M., Walbot, V. (1987). Introns increase gene expression in cultured maize cells. Genes Dev. 1:1183-1200.
- Carey, E. E., Dickinson, D. B., Wei, L. Y., Rhodes, A. M. (1982). Occurrence of sorbitol in Zea mays. Phytochemistry 21: 1909-1911.
- Centers for Disease Control and Prevention. (1996) Morbidity and Mortality Weekly Report 44 (SS-4):1-13.
- Cheng, L., Zhou, R., Reidel, E. J., Sharkey, T. D., Dandekar, A. M. (2005). Antisense inhibition of sorbitol synthesis leads to up-regulation of starch synthesis without altering CO2 assimilation in apple leaves. Planta 220:767-776.
- Chorey, P. S., Zurawki, D. B. (1981). Callus formation from protoplasts of a maize cell line. Theor. Appl. Genet. 59:341-344.
- Clancy, M. and Hannah, L. C. (2002) âSplicing of the maize Shl first intron is essential for enhancement of gene expression, and a T-rich motif increases expression without affecting splicingâ Plant Physiol. 130(2):918-29.
- Clough, S. J. & Bent, A. F. (1998) Plant J. 16:735-743.
- Cossins, E. A. & Chen, L. (1997) âFolates and one-carbon metabolism in plants and fungiâ Phytochemistry 45(3):437-452.
- Cossins, E. A. (2000) Can. J Bot. 78:691-708.
- de Boer, H. A., Comstock, L. J Vasser, M. (1983) âThe tac promoter: a functional hybrid derived from the trp and lac promotersâ Proc. Natl. Acad. Sci. USA 80(1):21-25.
- de Bree, A., van Dusseldorp, M., Brouwer, I. A., van het Hof, K. H. & Steegers-Theuniss-en, R. P. (1997) âFolate intake in Europe: recommended, actual and desired intakeâ Eur. J Clin. Nutr. 51(10):643-660.
- Deikman, J., Kline, R. & Fischer, R. L. (1992) Plant Physiol. 100:2013-2017.
- DellaPenna, D. (1999) âNutritional genomics: manipulating plant micronutrients to improve human healthâ Science 285(5426):375-379.
- Diaz de la Garza, R. D. Quinlivan, E. P., Klaus, S. M. J., Basset, G. J. C., Gregory, J. F., Hansen, A. D. (2004) Proc. Natl. Acad. Sci. USA 101: 13720-13725.
- Doehlert, D. C. (1987). Ketose activity in developing maize endosperm. Plant Physiol. 84:830-834.
- Doehlert, D. C., Kuo, T. M. (1990). Sugar metabolism in developing kernels of starch deficient endosperm mutants of maize. Plant Physiol. 92:990-994.
- Doehlert, D. C., Kuo, T. M., Felker, F. C. (1988). Enzymes of sucrose and hexose metabolism in developing kernels of two inbreds of maize. Plant Physiol. 86:1013-1019.
- Doehlert, D. C., Smith, L. J., Duke, E. R. (1994). Gene expression during maize kernel development. Seed Science Research 4:299-305.
- Duch, D. S., Browns, S. W., Wolf, J. H. & Nichol, C. A. (1984) âBiopterin cofactor biosynthesis: GTP cyclohydrolase, neopterin and biopterin in tissues and body fluids of mammalian speciesâ Life Sci. 35:1895-1901.
- Everard, J. D., Gucci, R., Kann, S. C., Flore, J. A., Loescher, W. H. (1994). Gas exchange and carbon partitioning in the leaves of celery (Apium graveolens L.) at various levels of root zone salinity. Plant Physiol. 106:281-292.
- Evert, R. F., Russin, W. A. (1993). Structurally, phloem unloading in the maize leaf cannot be symplastic. American Journal of Botany 80:1310-1317.
- Fell, D. A. (1998) âIncreasing the flux in metabolic pathways: A metabolic control analysis perspectiveâ Biotechnol. Bioeng. 58(2-3):121-124.
- Forrest, H. S. & Van Baalen, C. (1970) âMicrobiology of unconjugated pteridinesâ Annu. Rev. Microbiol. 24:91-108.
- Frame, B. R., McMurray, J. M., Fonger, T. M., Main, M. L., Taylor, K. W., Torney, F. J., Paz, M. M., Wang, K. (2006). Improved Agrobacterium-mediated transformation of three maize inbred lines using MS salts. Plant Cell Rep. 25, 1024-34.
- Freeling, M., Bennett, D. D. (1985). Maize Adhl. Annu. Rev. Genet. 19:297-323.
- Freitas, F. A., Yunes, J. A., da Silva, M. J., Arruda, P., Leite, A. (1994) Structural characterization and promoter activity analysis of the âĄ-kafirin gene from sorghum. Mol. Gen. Genet. 245:177-186.
- Fukushima, T. & Nixon, J. C. (1980) âAnalysis of reduced forms of biopterin in biological tissues and fluidsâ Anal. Biochem. 102(1):176-188.
- Furtado, A. et al. (2002) âTools for Use in the Genetic Engineering of Barleyâ Proceedings of the 10th Australian Barley technical Symposium, Canberra, ACT, Australia.
- Gao, Z., Loescher, W. H. (2000). NADPH supply and mannitol biosynthesis. Characterization, cloning, and regulation of the non-reversible glyceraldehydes-3-phosphate dehydrogenase in celery leaves. Plant Physiol. 124:321-330.
- Gao, Z., Maurousset, L., Lemoine, R., Yoo, S. D., van Nocker, S., Loescher, W. (2003). Cloning, expression, and characterization of sorbitol transporters from developing sour cherry fruit and leaf sink tissues. Plant Physiol. 131:1566-1575.
- Geigenberger, P., Langenberger, S., Wilke, I., Heineke, D., Heldt, H.W., Stitt, M. (1993). Sucrose is metabolised by sucrose synthase and glycolysis within the phloem complex of Ricinus communis L. seedlings. Planta 190: 446-453.
- Good, X. et al. (1994) âReduced ethylene synthesis by transgenic tomatoes expressing S-adenosylmethionine hydrolaseâ Plant Molec. Biol. 26:781-790.
- Goyer, A., Illarionova, V., Roje, S., Fischer, M., Bacher, A. & Hanson, A. D. (2004) âFolate biosynthesis in higher plants. cDNA cloning, heterologous expression, and characterization of dihydroneopterin aldolasesâ Plant Physiol. 135(1):103-111.
- Green, J. M., Merkel, W. K., Nichols, B. P. (1992) âCharacterization and Sequence of Escherichia coli pabC, the gene encoding aminodeoxychorismate lyase, a pyridoxal phosphate-containing enzymeâ Journal of Bacteriology 174:5317-5323.
- Gregory, J. F. III & Toth, J. P. (1988) âChemical synthesis of deuterated folate monoglutamate and in vivo assessment of urinary excretion of deuterated folates in manâ Anal. Biochem. 170(1): 94-104.
- Grennan, A K (2007) âThe role of trehalose biosynthesis in plantsâ Plant Physiol. 144:3-5.
- Grossowicz, N., Waxman, S. & Schreiber, C. (1981) âCryoprotected Lactobacillus casei: an approach to standardization of microbiological assay of folic acid in serumâ Clin. Chem. 27:745-747.
- Hanson, A. D. & Gregory, J. F. III (2002) âSynthesis and turnover of folates in plantsâ Curr. Opin. Plant Biol. 5(3):244-249.
- Haselhoff and Gerlach Nature 334:585-591 (1988).
- Home, D. W. & Patterson, D. (1988) âLactobacillus Casei Microbiological Assay of Folic Acid Derivatives in 96-well Microtiter Platesâ Clin. Chem. 34:2357-2359.
- Hossain, T., Rosenberg, I., Selhub, J., Kishore, G., Beachy, R. & Schubert, K. (2004) âEnhancement of folates in plants through metabolic engineeringâ Proc. Natl. Acad. Sci. USA 101(14):5158-5163.
- Huber, S. C., Akazawa, T. (1986). A novel sucrose synthase pathway for sucrose degradation in cultured sycamore cells. Plant Physiol. 81: 1008-1013.
- Hwang, Y-S. et al. (2002) âAnalysis of the Rice Endosperm-Specific Globulin Promoter in Transformed Rice Cellsâ Plant Cell Rep. 20:842-847.
- Iida, M., Bantog, N. A., Yamada, K., Shiratake, K., Yamaki, S. (2004). Sorbitol and other sugar-induced expression of the NAD+-dependent sorbitol dehydrogenase gene in Japanese pear fruit. J. of American Soc. for Hort. Science 129:870-875.
- James, M. G., Denyer, K., Myers, A. M. (2003). Starch synthesis in the cereal endosperm. Curr. Opin. Plant Biol. 6:215-222.
- Jeong, Y. M., Mun, J. H., Lee, I., Woo, J. C., Hong, C. B., Kim, S. G. (2006). Distinct roles of the first introns on the expression of Arabidopsis profiling gene family members. Plant Physiol. 140:196-209.
- Karlin S. and Altschul, S. F. (1990) âMethods for Assessing the Statistical Significance of Molecular Sequence Features by Using General Scoring Schemesâ Proc. Natl. Acad. Sci. USA 87:2264-2268.
- Karlin S. and Altschul, S. F. (1993) âApplications and Statistics for Multiple High-Scoring Segments in Molecular Sequencesâ Proc. Natl. Acad. Sci. USA 90:5873-5877.
- Koch, K. (2004). Sucrose metabolism: regulatory mechanisms and pivotal roles in sugar sensing and plant development. Curr. Opin. Plant. Bio1.7: 235-46.
- Koch, K. E., Avigne, W. T. (1990). Post-phloem, nonvascular transfer in citrus: Kinetics, metabolism, and sugar gradients. Plant Physiol. 93:1405:1416.
- Koch, K. E., Nolte, K. D., Duke, E. R., McCarty, D. R., Avigne, W. T. (1992). Sugar levels modulate differential expression of maize sucrose synthase genes. Plant Cell 4:59-69.
- Koch, K. E., Tsui, C. L., Schrader, L. E., Nelson, O. E. (1982). Source-sink relations in maize mutants with starch-deficient endosperm. Plant Physiol. 70:322-325.
- Koch, K. E., Zeng, Y., Wu, Y., Avigne, W. T. (2000). Multiple paths of sugar-sensing and a sugar/oxygen overlap for genes of sucrose and ethanol metabolism. J. Exp. Bot. 51:417-427.
- Koch, K E (1996) Carbohydrate-modulated gene expression in plants. Ann Rev Plant Physiol and Plant Mol Bio. 47:509-540.
- Kohashi, M. (1980) âIsolation of Six Unconjugated Pteridines From Soybean (Glycin max L. Tsurunoko) Seedsâ J Biochem. 87:1581-1586.
- Kohashi, M., Tomita, K. & Iwai, K. (1980) Agric Biol Chem. 44:2089-2094.
- Konings, E. J., Roomans, H. H., Dorant, E., Goldbohm, R. A., Saris, W. H. & van den Brandt, P. A. (2001) âFolate intake of the Dutch population according to newly established liquid chromatography data for foodsâ Am. J. Clin. Nutr. 73(4):765-776.
- Koziel, M. G., Carozzi, N. B. & Desai, N. (1996) âOptimizing expression of transgenes with an emphasis on post-transcriptional eventsâ Plant Mol. Biol. 32(1-2):393-405.
- Krishnaswamy, K. & Madhavan Nair, K. (2001) âImportance of folate in human nutritionâ Br. J. Nutr. 85:S115-S124.
- Laemmli, U. K. (1970) Nature 227:680-685.
- Lemire, R. J. (1998) JAMA 259:558-562.
- Lewin, B. (1985) Genes II, John Wiley & Sons, Inc., p. 96.
- Lin, X. L. & White, R. H. (1988) âStructure of Solfapterin (erythro-Neopterin-3âČ-D-2-Deoxy-2-Aminoglucopyranoside) Isolated from the Thermophilic Archaebacterium Sulfolobus solfataricusâ J. Bacteriol. 170:1396-1398.
- Lo Bianco, R., Rieger, M., Sung, S. J. S. (1999a). Activities of sucrose and sorbitol metabolizing enzymes in vegetative sinks of peach and correlation with sink growth rate. J. of American Soc. of Hort. Science 124:381-388.
- Lo Bianco, R., Rieger, M., Sung, S. J. S. (1999b). Carbohydrate metabolism of vegetative and reproductive sinks in the late maturing peach cultivar âEncoreâ. Tree Physiology 19:103-109.
- Loescher, W. H. (1987).Physiology and metabolism of sugar alcohols in higher plants. Physiologia Plantarum 70:553-557.
- Loescher, W. H., Everard, J. D. (1996). Sugar alcohol metabolism in sinks and sources. In Zamski,E., Shaffer, A. A., eds, Photoassimilate distribution in plant and crops: Source-sink relationships. Marcel Dekker, New York, 185-207.
- Loescher, W. H., Marlow, G. C., Kennedy, R. A. (1982). Sorbitol metabolism and sink-source interconversions in developing apple leaves. Plant Physiol. 70:335-339.
- Lucock, M. (2000) âFolic acid: nutritional biochemistry, molecular biology, and role in disease processesâ Mol. Genet. Metab. 71(1-2):121-138.
- Maniatis, T., E. F. Fritsch, J. Sambrook (1982) âNuclease Bal31â Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
- Maret, W. Auld, D. S. (1998). Purification and characterization of human liver sorbitol dehydrogenase. Biochemistry 27:1622-1628.
- Marini, I., Bucchioni, L., Borella, P. Corso, A. D., Mura, U. (1997). Sorbitol dehydrogenase form bovine lens: purification and properties. Arch. Biochem. Biophys. 340:383-391.
- Mascarenhas, D., Mettler, I. J., Pierce, D. A., Lowe, H. W. (1990). Intron-mediated enhancement of heterologous gene expression in maize. Plant Mol. Biol. 15:913-920.
- McCarty, D. R., A. M. Settles, M. Suzuki, B.C. Tan, S. Latshaw, T. Porch, K. Robin, J. Baier, W. T. Avigne, J. Lai, J. Messing, K. E. Koch, L. C. Hannah. (2005). Steady-state transposon mutagenesis in inbred maize. Plant J. 44: 52-61.
- McElroy, D., Zhang, W., Cao, J., Wu, R. (1990). Isolation of an efficient actin promoter for use in rice transformation. Plant Cell 2:163-171.
- Merlo, L., Passera, C. (1991). Changes in carbohydrate and enzyme levels during development of leaves of Prunus persica, a sorbitol synthesizing species. Physiologia Plantarum 83:621-626.
- Milstien, S., Jaffe, H., Kowlessur, D. & Bonner, T. I. (1996) âPurification and Cloning of the GTP Cyclohydrolase I Feedback Regulatory Protein, GFRPâ J. Biol. Chem. 271:19743-19751.
- Molloy, A. M. & Scott, J. M. (2001) âFolates and prevention of diseaseâ Public Health Nutr. 4(2B):601-609.
- Moore, C. A., Li, S., Li, Z. Hong, S., Gu, H., Berry, R. J., Mulinare, J. & Ericson, J. D. (1997) Am. J. Med. Gen. 73:113-118
- Morita, A., Umemura, T., Kuroyanagi, M., Futsuhara, Y., Perata, P., Yamagushi, J.
- (1998). Functional dissection of a sugar-repressed alpha-amylase gene (Ramy1A) promoter in rice embryos. FEBS lett 423:81-85.
- Negm, F. B., Loescher, W. H. (1979). Detection and characterization of sorbitol dehydrogenase from apple callus tissue. Plant Physiol. 64:69-73.
- Negm, F. B., Loescher, W. H. (1981). Characterization and partial purification of aldose-6-6-phosphate reductase (Alditol-6-phosphate:NADP 1-oxidoreductase) form apple leaves. Plant Physiol. 67:139-142.
- Ng, K., Ye, R., Wu, X. C., Wong, S.-L. (1992). Sorbitol dehydrogenase from Bacillus subtilis. J. Biol. Chem. 267: 24989-24994.
- Noiraud, N., Delrot, S., Lemoine, R. (2000). The sucrose transporter of celery. Identification and expression during salt stress. Plant Physiol. 122:1447-1455.
- Nolte, K. D., Hendrix, D. L., Radin, J. W., Koch, K .E. (1995). Sucrose synthase localization during initiation of seed development and trichome differentiation in cotton ovules. Plant Physiol. 109:1285-1293.
- Nolte, K. D., Koch, K. E. (1993). Companion-cell specific localization of sucrose synthase in zones of phloem loading and unloading. Plant Physiol. 101:899-905.
- Nuccio, M. L. & Thomas, T. L. (1999) âATS1 and ATS3: two novel embryo-specific genes in Arabidopsis thalianaâ Plant Mol. Biol. 39(6):1153-1163.
- Ohto, M-A, K Onai, Y Furukawa, E Aoki, A Takashi, and K Nakamura (2001) Plant Physiol. 127:252-261.
- Pfeiffer, C. M. & Gregory, J. F. III (1996) âEnzymatic deconjugation of erythrocyte polyglutamyl folates during preparation for folate assay: investigation with reversed-phase liquid chromatographyâ Clin. Chem. 42(11):1847-1854.
- Quinlivan, E. P., Roje, S., Basset, G., Shachar-Hill, Y., Gregory, J. F. III & Hanson, A. D. (2003) âThe folate precursor p-aminobenzoate is reversibly converted to its glucose ester in the plant cytosolâ J. Biol. Chem. 278(23):20731-20737.
- Ravanel, S., Cherest, H., Jabrin, S., Grunwald, D., Surdin-Kerjan, Y., Douce, R. & RĂ©beillĂ©, F. (2001) âTetrahydrofolate biosynthesis in plants: molecular and functional characterization of dihydrofolate synthetase and three isoforms of folylpolyglutamate synthetase in Arabidopsis thalianaâ Proc. Natl. Acad. Sci. USA 98(26):15360-15365.
- Sambrook, J., Fritsch, E. F. & Maniatis, T. (1989) Molecular Cloning. A Laboratory Manual (Cold Spring Harbor Laboratory Press, New York), pp 14.18-14.19.
- Scholl, T. O. et al. (2000) âFolic Acid: Influence on the Outcome of Pregnancyâ Am. J. Clin. Nutr. 71S:1295S-1303S.
- Scott, J., Rebeille, F. & Fletcher, J. (2000) âFolic acid and folates: the feasibility for nutritional enhancement in plant foodsâ J. Sci. Food Agric. 80:795-824.
- Stea, B., Halpern, R. M., Halpern, B. C. & Smith, R. A. (1980) âQuantitative determination of pterins in biological fluids by high-performance liquid chromatographyâ J. Chromatogr. 188(2):363-375.
- Swedlund, B., Locy, R. D. (1993) âSorbitol as the primary carbon source for the growth of embryogenic callus of maizeâ Plant Physiol. 103:1339-1346.
- Sybesma, W., Starrenburg, M., Kleerebezem, M., Mierau, I., de Vos, W. M. & Hugenholtz, J. (2003a) âIncreased production of folate by metabolic engineering of Lactococcus lactisâ Appl. Environ. Microbiol. 69(6):3069-3076.
- Sybesma, W., Starrenburg, M., Tijsseling, L., Hoefnagel, M. H. & Hugenholtz, J. (2003b) âEffects of cultivation conditions on folate production by lactic acid bacteriaâ Appl. Environ. Microbiol. 69(8):4542-4548.
- Tieman, D. M., Ciardi, J. A., Taylor, M. G. & Klee, H. J. (2001) âMembers of the tomato LeEIL (EIN3-like) gene family are functionally redundant and regulate ethylene responses throughout plant developmentâ Plant J. 26(1):47-58.
- Van der Meer, I. M., Bovy, A. G. & Bosch, D. (2001) âPlant-based raw material: improved food quality for better nutrition via plant genomicsâ Curr. Opin. Biotechnol. 12(5):488-492.
- Verma, I. C. (1978) Lancet 1:879-80.
- Viswanathan, V. K., Green, J. M., Nichols, B. P. (1995) âKinetic Characterization of 4-Amino-4-Deoxychorismate Synthase from Escherichia coliâ Journal of Bacteriology 177(20):5918-5923.
- Webb, K., Burley, J. W. A. (1962). Sorbitol translocation in apple. Science 137:766.
- Wilson, S. D. & Home, D. W. (1982) âUse of Glycerol-Cryoprotected Lactobacillus Casei for Microbiological Assay of Folic Acidâ Clin. Chem. 28:1198-1200.
- Win, T. (2000) Dissertation, Institute of Chemistry and Biology of the Marine Environment (UniversitÀt of Oldenburg, 26111 Oldenburg Germany), pp. 63-66.
- Wu, C-L. et al. (1998) âPromoters of Rice Seed Storage Protein Genes Direct Endosperm-Specific Gene Expression in Transgenic Riceâ Plant and Cell Physiology, 39(8):885-889.
- Xu, D., McElroy, D., Thornburg, R. W., Wu, R. et al. (1993) âSystemic induction of a potato pin2 promoter by wounding, methyl jasmonate, and abscisic acid in transgenic rice plantsâ Plant Molecular Biology 22:573-588.
- Yang, T. T. et al. (1996) âOptimized Codon Usage and Chromophore Mutations Provide nhanced Sensitivity with the Green Fluorescent Proteinâ Nucleic Acid Research 24(22):4592-4593.
- Yim, J. J. et al. (1976) âCharacteristics of Guanosine Triphosphate Cyclohydrolase I Purified From Escherichia coliâ J. Biol. Chem. 251:5087-5094.
- Yoneyama, T. & Hatakeyama, K. (1998) âDecameric GTP cyclohydrolase I forms complexes with two pentameric GTP cyclohydrolase I feedback regulatory proteins in the presence of phenylalanine or of a combination of tetrahydrobiopterin and GTPâ J. Biol. Chem. 273(32):20102-20108.
- Zhang, G. F., Maudens, K. E., Storozhenko, S., Mortier, K. A., Van Der Straeten, D. & Lambert, W. E. (2003) âDetermination of total folate in plant material by chemical conversion into para-aminobenzoic acid followed by high performance liquid chromatography combined with on-line postcolumn derivatization and fluorescence detectionâ J. Agric. Food Chem. 51(27):7872-7878.
- Campos, H., Cooper A., Habben, J. E., Edmeades, G. O, Schussler, J. R. (2004) âImproving drought tolerance in maize: a view from industryâ Field Crops Research 90:19-34.
- Lida, M., Bantog, N. A., Yamada, K., Shiratake, K., Yamaki, S. (2004). Sorbitol and other sugar-induced expression of the NAD+-dependent sorbitol dehydrogenase gene in Japanese pear fruit. J. of American Soc. for Hort. Science 129:870-875.
- Nosarszewski, M., Clements, A. M., Downie, B., Archbold, D. D. (2004). Sorbitol dehydrogenase expression and activity during apple fruit set and early development. Physiologia Plant.121: 391-398.
- Oura, Y., Yamada, K., Shiratake, K., Yamaki, S. (2000). Purification and characterization of a NAD+-dependent sorbitol dehydrogenase form Japanese pear fruit. Phytochemistry 54: 567-572.
- Plaxton, W. C., Podesta, F. E. (2006). The Functional Organization and Control of Plant Respiration. Critical Reviews in Plant Sciences 25:159-198.
- Park, S. W., Song, K. J., Kim, M. Y., Hwang, J-H., Shin, Y. U., Kim, W-C., Chung, W-II. (2002). Molecular cloning and characterization of four cDNAs enconding the isoforms of NAD-dependent sorbitol dehydrogenase from the Fuji apple. Plant Science 162:513-519.
- Rolletschek, H., Koch, K., Wobus, U., Borisjuk, L. (2005). Positional cues for starch/lipid balance in maize kernels and resource portioning to the embryo. Plant J. 42: 69-83.
- Teo, G. Suzuki, Y., Uratsu, S. L., Lampinen, B., Ormonde, N., Hu, W. K., DeJong, T. M., Dandekar, A. M. (2006). Silencing leaf sorbitol synthesis alters long-distance partitioning and apple fruit quality. PNAS 103:18842-18847.
- Touster, O., Shaw, D. R. D. (1962). Biochemistry of acyclic polyols. Physiol. Rev. 42:181-225.
- Yamaguchi, H., Kanayama, Y., Yamaki, S. (1994). Purification and properties of NAD-dependent sorbitol dehydrogenase form apple fruit. Plant Cell Physiol. 35:887-892.
- Yamada, K., Oura, Y., Mori, H., Yamaki, S. (1998). Cloning of NAD-dependent sorbitol dehydrogenase from apple fruit and gene expression. Plant Cell Physiol. 39: 1375-1379.
- Zhou, R., Cheng, L., Wayne, R. (2003). Purification and characterization of sorbitol-6-phosphate phosphatase from apple leaves. Plant Science 165:227-232.
- Zhou, R., Cheng, L., Dandekar, A. M. (2006). Down-regulation of sorbitol dehydrogenase and up-regulation of sucrose synthase in shoot tips of the transgenic apple trees with decreased sorbitol synthesis. J. Exp. Bot. 57:3647-3657.
- Zimmermann, M. H., Ziegler, H. (1975). List of sugars and sugar alcohols in sieve-tube exudates. In: Transport in Plants I: Phloem transport. Springer-Verlag Berlin Heidelberg, New York.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/019,951 US20210000060A1 (en) | 2007-05-18 | 2020-09-14 | Materials and methods for modulating seed size, seed number, and seed sugar content in plants |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93080307P | 2007-05-18 | 2007-05-18 | |
US95860507P | 2007-07-06 | 2007-07-06 | |
PCT/US2008/064130 WO2008144653A1 (en) | 2007-05-18 | 2008-05-19 | Materials and methods for modulating seed size, seed number, and seed sugar content in plants |
US59965210A | 2010-11-05 | 2010-11-05 | |
US17/019,951 US20210000060A1 (en) | 2007-05-18 | 2020-09-14 | Materials and methods for modulating seed size, seed number, and seed sugar content in plants |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/599,652 Continuation US10813324B2 (en) | 2007-05-18 | 2008-05-19 | Materials and methods for modulating seed size, seed number, and seed sugar content in plants |
PCT/US2008/064130 Continuation WO2008144653A1 (en) | 2007-05-18 | 2008-05-19 | Materials and methods for modulating seed size, seed number, and seed sugar content in plants |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210000060A1 true US20210000060A1 (en) | 2021-01-07 |
Family
ID=40122191
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/599,652 Active 2029-08-31 US10813324B2 (en) | 2007-05-18 | 2008-05-19 | Materials and methods for modulating seed size, seed number, and seed sugar content in plants |
US17/019,951 Pending US20210000060A1 (en) | 2007-05-18 | 2020-09-14 | Materials and methods for modulating seed size, seed number, and seed sugar content in plants |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/599,652 Active 2029-08-31 US10813324B2 (en) | 2007-05-18 | 2008-05-19 | Materials and methods for modulating seed size, seed number, and seed sugar content in plants |
Country Status (2)
Country | Link |
---|---|
US (2) | US10813324B2 (en) |
WO (1) | WO2008144653A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014057315A1 (en) * | 2012-10-10 | 2014-04-17 | Biocon Limited | A nucleotide sequence and a process thereof |
WO2014161908A1 (en) | 2013-04-05 | 2014-10-09 | Bayer Cropscience Nv | Brassica plants comprising mutant da1 alleles |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274379B1 (en) * | 1998-07-15 | 2001-08-14 | E. I. Du Pont De Nemours & Company | Plant sorbitol biosynthetic enzymes |
US20090087878A9 (en) * | 1999-05-06 | 2009-04-02 | La Rosa Thomas J | Nucleic acid molecules associated with plants |
-
2008
- 2008-05-19 US US12/599,652 patent/US10813324B2/en active Active
- 2008-05-19 WO PCT/US2008/064130 patent/WO2008144653A1/en active Application Filing
-
2020
- 2020-09-14 US US17/019,951 patent/US20210000060A1/en active Pending
Non-Patent Citations (1)
Title |
---|
Tomkins et al., Crop Science, Vol. 42, pp. 928-933, May-June 2002. * |
Also Published As
Publication number | Publication date |
---|---|
US20110191909A1 (en) | 2011-08-04 |
US10813324B2 (en) | 2020-10-27 |
WO2008144653A1 (en) | 2008-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11814636B2 (en) | Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline conditions | |
HU218048B (en) | Process for producing transgenic plants altered in habitus and yeald with utilyzing plasmides | |
JP3431177B2 (en) | Plasmids producing transgenic plants altered in habit and yield | |
US20210000060A1 (en) | Materials and methods for modulating seed size, seed number, and seed sugar content in plants | |
US8536407B2 (en) | Heat resistant plants and plant tissues comprising a variant adenosine diphosphate glucose pyrophosphorylase small subunit protein and methods of use thereof | |
AU730471B2 (en) | Phosphate starvation-inducible proteins | |
US8362321B2 (en) | Methods and materials for increasing starch biosynthesis in plants | |
US20180355366A1 (en) | Yield promoter to increase sucrose and sucrose derivatives in plants | |
US8710298B2 (en) | Heat stable variants of plant adenosine diphosphate glucose pyrophosphorylase small subunit | |
US20040064851A1 (en) | Transgenic plants which produce isomalt | |
US6930227B1 (en) | Camellia sinensis gene encoding a caffeine synthesis associated n-methyl transferase with 7-methylxanthine n3 methyl transferase, theobromine n1 methyl transferase, and paraxanthine n3 methyl transferase activities and use thereof | |
US8709811B2 (en) | Materials and methods for synthesis of a flavor and aroma volatile in plants | |
US20240102041A1 (en) | Nucleotide sequences and corresponding polypeptides conferring modulated growth rate and biomass in plants grown in saline conditions | |
US20140259224A1 (en) | Transgenic plants with enhanced traits and methods of producing thereof | |
RU2145636C1 (en) | Method of inducing plant flowering | |
US20030073828A1 (en) | Epimerase gene and use thereof | |
JPH11514239A (en) | Modification of soluble solids using sucrose phosphate synthase coding sequence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |